{
  "meta": {
    "title": "00356_Late_Night_Pyq_Pyt_Obg-4",
    "url": "https://brainandscalpel.vercel.app/00356-late-night-pyq-pyt-obg-4-13a18676.html",
    "scrapedAt": "2025-11-29T17:29:25.206Z"
  },
  "questions": [
    {
      "id": 55314,
      "choices": [
        {
          "id": 220717,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia</span></span></span></p>"
        },
        {
          "id": 220718,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gestational HTN</span></span></span></p>"
        },
        {
          "id": 220719,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic HTN</span></span></span></p>"
        },
        {
          "id": 220720,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic HTN with superimposed preeclampsia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A G2P1 at 17 weeks presented to the OPD with a BP of 148/90 mmHg. Six hours later, her BP is 142/90 mmHg. What is the diagnosis? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q8002845",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585285,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Chronic HTN</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In pregnancy, the timing of hypertension onset is critical in determining the diagnosis. Chronic hypertension is defined as high blood pressure that is present before pregnancy or that is diagnosed before 20 weeks of gestation. This patient&#39;s blood pressure readings of 148/90 mmHg and 142/90 mmHg at 17 weeks of gestation indicate hypertension occurring before the 20-week threshold, fitting the definition of chronic hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To confirm chronic hypertension, if the patient&#39;s blood pressure remains elevated 12 weeks postpartum, the diagnosis is solidified.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Preeclampsia:</strong> This is incorrect because preeclampsia is characterized by hypertension that develops after 20 weeks of gestation and is accompanied by proteinuria. This patient&#39;s hypertension was noted before 20 weeks and there is no mention of proteinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Gestational HTN:</strong> This option is incorrect as gestational hypertension also develops after 20 weeks of gestation. This patient&#39;s hypertension was detected at 17 weeks, making this diagnosis unlikely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Chronic HTN with superimposed preeclampsia:</strong> This is incorrect because superimposed preeclampsia would require evidence of new-onset proteinuria or worsening hypertension after 20 weeks of gestation in a patient with pre-existing chronic hypertension. There is no mention of proteinuria in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension diagnosed before 20 weeks of gestation in a pregnant woman is most likely chronic hypertension.</span></span></span></p>",
      "correct_choice_id": 220719,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5751,
      "choices": [
        {
          "id": 22975,
          "text": "<p><span style=\"font-size:12pt;\">0</span></p>"
        },
        {
          "id": 22976,
          "text": "<p><span style=\"font-size:12pt;\">3</span></p>"
        },
        {
          "id": 22977,
          "text": "<p><span style=\"font-size:12pt;\">5</span></p>"
        },
        {
          "id": 22978,
          "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida came to the labor room at 40 weeks + 5 days gestation for induction of labor. On per vaginal examination, the cervix is less then 1 cm dilated and length is 3 cm. The vertex is at -2 station and the cervix is soft and anterior. What will be the bishop score for this lady?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q2642705",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585331,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop's score, in this case, is 5.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.</span></li><li><span style=\"font-size:12pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.</span></li><li><span style=\"font-size:12pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).</span></li><li><span style=\"font-size:12pt;\">The 5 components of the Modified Bishop score are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/untitled-294.jpg\" alt=\"\" width=\"500\" height=\"272\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_w6olTxi.png\" width=\"1404\" height=\"355\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop score is used to evaluate the readiness of the cervix for induction of labor. A score of 6 or more suggests that the cervix is favorable for induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22977,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5998,
      "choices": [
        {
          "id": 23962,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 cm</span></span></span></p>"
        },
        {
          "id": 23963,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 cm</span></span></span></p>"
        },
        {
          "id": 23964,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7 cm</span></span></span></p>"
        },
        {
          "id": 23965,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10 cm</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the normal uterocervical length?&nbsp;</span></span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5940145",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585325,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 7 cm</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal length of the uterine cavity, including the cervical canal, is usually 6-7 cm. This measurement is essential in gynecological evaluations and procedures.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement helps in assessing normal uterine anatomy and can be used in various clinical procedures such as the insertion of intrauterine devices (IUDs).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovary:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The ovary measures about 3 cm x 2 cm x 1 cm.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fallopian Tube:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The length of the Fallopian tube is about 10 cm, and the lumen is 1-2 mm at the isthmus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal length of the uterine cavity, including the cervical canal, is 6-7 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition Pg 25, Dutta&#39;s textbook of gynecology 6<sup>th</sup> edition Pg 7</span></strong></span></span></p>",
      "correct_choice_id": 23964,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5911,
      "choices": [
        {
          "id": 23614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left axis deviation</span></span></span></p>"
        },
        {
          "id": 23615,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild ST changes in inferior leads</span></span></span></p>"
        },
        {
          "id": 23616,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial and ventricular premature contractions</span></span></span></p>"
        },
        {
          "id": 23617,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pansystolic murmur</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are normal physiological changes in pregnancy except?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q3387233",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585290,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pansystolic murmur </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During pregnancy, there are several physiological changes in the cardiovascular system:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Examination:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jugular venous distension and venous hum are commonly observed.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mammary souffl&eacute;: A continuous murmur can be heard at the 2nd to 4th intercostal spaces.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow murmurs at the aortic or pulmonary areas.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased and widely split S1 sound.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S2 P component is increased, and S2 is split.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The apex beat is shifted to the 4th intercostal space, 2.5 cm outside the mid-clavicular line.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electrocardiography:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T wave inversion and bi-atrial enlargement.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Various dysrhythmias, including atrial and ventricular premature contractions, are relatively frequent.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the diaphragm being elevated during advancing pregnancy, there is an average 15-degree left-axis deviation in the electrocardiogram (ECG), and mild ST changes may be seen in the inferior leads.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy does not alter voltage.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tricuspid regurgitation may be present.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased left atrial end-diastolic dimension and left ventricular mass.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Left axis deviation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a normal change due to the diaphragm being elevated during pregnancy, causing an average 15-degree left-axis deviation in the ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Mild ST changes in inferior leads:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These are normal and can be seen due to the changes in heart position and function during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Atrial and ventricular premature contractions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These are relatively frequent and considered normal in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diastolic and pansystolic murmurs in pregnancy are not normal and should be investigated further.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 178, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23617,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6010,
      "choices": [
        {
          "id": 24010,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echocardiography for cardiac disease</span></span></span></p>"
        },
        {
          "id": 24011,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine analysis for bacteriuria</span></span></span></p>"
        },
        {
          "id": 24012,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood sugar levels for GDM</span></span></span></p>"
        },
        {
          "id": 24013,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VDRL for syphilis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following cost-effective investigations are routinely recommended in the screening of antenatal mothers except?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q4144623",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585334,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Echocardiography for cardiac disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echocardiography for cardiac disease is not part of routine antenatal screening. While it is important for detecting cardiac conditions, echocardiography is typically performed only if there is a known or suspected cardiac disease. Routine screening for all antenatal mothers does not include echocardiography due to its cost and the specific indications required for its use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Routine antenatal screening is designed to identify common conditions that may affect the health of the mother and baby. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Urine analysis for bacteriuriaUrine analysis for bacteriuria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This test is routinely performed to detect asymptomatic bacteriuria, which, if left untreated, can lead to urinary tract infections and increase the risk of preterm labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Blood sugar levels for GDM Blood sugar levels for GDM (Gestational Diabetes Mellitus):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Screening for GDM is essential to identify women who develop diabetes during pregnancy, which can affect both maternal and fetal health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. VDRL for syphilis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The VDRL (Venereal Disease Research Laboratory) test is a screening tool for syphilis, a sexually transmitted infection that can have serious consequences for both the mother and the baby if left untreated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Routine antenatal screening does not include echocardiography for cardiac disease unless there is a known or suspected condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 110, DC Dutta&rsquo;s Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5833,
      "choices": [
        {
          "id": 23302,
          "text": "<p><span style=\"font-size:12pt;\">Calymmatobacterium granulomatis</span></p>"
        },
        {
          "id": 23303,
          "text": "<p><span style=\"font-size:12pt;\">Chlamydia trachomatis</span></p>"
        },
        {
          "id": 23304,
          "text": "<p><span style=\"font-size:12pt;\">Ureaplasma urealyticum</span></p>"
        },
        {
          "id": 23305,
          "text": "<p><span style=\"font-size:12pt;\">Treponema pallidum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the causative agent for granuloma inguinale?</span><span style=\"font-size:12.0pt;\"> (NEET PG 2020)&nbsp;</span></p>",
      "unique_key": "Q8063288",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585313,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Calymmatobacterium granulomatis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The causative agent for granuloma inguinale (donovanosis) is Calymmatobacterium granulomatis.</span></li><li><span style=\"font-size:12pt;\">It is now called Klebsiella granulomatis and is a gram-negative bacillus causing chronic ulcerative infection of the vulva.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Chlamydia trachomatis</strong>: Causes pelvic inflammatory disease</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ureaplasma urealyticum</strong>: Causes urethritis</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Treponema pallidum</strong>: Causes syphilis</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Sexually Transmitted Infections</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-161024.png\" alt=\"\" width=\"1000\" height=\"764\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Granuloma inguinale, also known as donovanosis, is caused by Klebsiella granulomatis (formerly Calymmatobacterium granulomatis).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 146, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21774,
      "choices": [
        {
          "id": 87060,
          "text": "<p><span style=\"font-size:12pt;\">Type 1 hysterectomy</span></p>"
        },
        {
          "id": 87061,
          "text": "<p><span style=\"font-size:12pt;\">Type 2 hysterectomy</span></p>"
        },
        {
          "id": 87062,
          "text": "<p><span style=\"font-size:12pt;\">Type 3 hysterectomy</span></p>"
        },
        {
          "id": 87063,
          "text": "<p><span style=\"font-size:12pt;\">Type 4 hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman is diagnosed with CA cervix. Investigations revealed a lesion of 3.5 cm. What can the appropriate management?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q2003911",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585282,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Type 3 hysterectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient has CA cervix Stage 1B2 and the management will be Type 3 / Radical hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">FIGO Revised staging of cervical cancer (2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-104746.png\" alt=\"\" width=\"1000\" height=\"716\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>TREATMENT</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Surgery: for early stages like stage 1, stage 2A1</span></li><li><span style=\"font-size:12pt;\">Radiotherapy: for all patients from Stage 1 to 4</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-104945.png\" alt=\"\" width=\"1000\" height=\"252\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type 1: Simple extra fascial hysterectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type 2: Modified radical hysterectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type3: Radical Hysterectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type4: Extended Radical hysterectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Type 5: Partial Exenteration</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Type 1 hysterectomy (Simple extra fascial hysterectomy):</strong> Suitable for Stage 1A1 (without lymph-vascular space invasion - LVSI) or conization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Type 2 hysterectomy (Modified radical hysterectomy):</strong> Suitable for Stage 1A1 (with LVSI) and Stage 1A2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Type 4 hysterectomy (Extended radical hysterectomy):</strong> Typically used for more advanced stages or extensive disease beyond Stage 1B2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cervical cancer staging, a lesion size between 2 to 4 cm (Stage 1B2) is best managed with a Type 3 (Radical) hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: FIGO Revised Staging of Cervical Cancer, Berek and Novak’s Gynaecology 15<sup>th</sup> Edition, Dutta’s textbook of Gynaecology 8<sup>th</sup> edition page367</strong></span></p>",
      "correct_choice_id": 87062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5818,
      "choices": [
        {
          "id": 23242,
          "text": "<p><span style=\"font-size:12pt;\">Continue warfarin throughout the pregnancy</span></p>"
        },
        {
          "id": 23243,
          "text": "<p><span style=\"font-size:12pt;\">Replace warfarin with heparin in first trimester</span></p>"
        },
        {
          "id": 23244,
          "text": "<p><span style=\"font-size:12pt;\">Give accoumarin</span></p>"
        },
        {
          "id": 23245,
          "text": "<p><span style=\"font-size:12pt;\">Use LMW heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant female with known cardiac disease presents in the first trimester with history of warfarin embryopathy. What should be advised now?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q2513391",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585307,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Replace warfarin with heparin in first trimester</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Warfarin readily crosses the placenta and is associated with teratogenic effects, particularly when exposure occurs between the 6th and 9th weeks of pregnancy. Warfarin embryopathy is characterized by stippled epiphysis and nasal hypoplasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Management guidelines for pregnant women with mechanical heart valves requiring anticoagulation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>First trimester:</strong> Women on warfarin should be switched to heparin as soon as pregnancy is diagnosed to avoid teratogenic effects.</span></li><li><span style=\"font-size:12pt;\"><strong>Second and third trimesters (13 to 36 weeks):</strong> Warfarin can be resumed as it is the most effective anticoagulant in preventing thromboembolic events.</span></li><li><span style=\"font-size:12pt;\"><strong>Near delivery:</strong> Warfarin should be switched back to heparin around delivery to avoid complications. Heparin should be stopped prior to delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mechanical heart valves:</strong> Require lifelong anticoagulation, whereas bioprosthetic valves do not require lifelong anticoagulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Continue warfarin throughout the pregnancy:</strong> Continuing warfarin throughout the pregnancy is not advisable due to the risk of warfarin embryopathy and potential fetal hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Give accoumarin:</strong> Accoumarin is not a standard recommendation for anticoagulation in pregnant women with mechanical heart valves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Use LMW heparin:</strong> While low molecular weight heparin (LMWH) is safer in pregnancy compared to warfarin, the specific recommendation is to switch to heparin in the first trimester and possibly back to warfarin in the second and third trimesters, depending on individual risk assessments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In pregnant women with mechanical heart valves on warfarin, switch to heparin as soon as pregnancy is diagnosed in the first trimester to avoid teratogenic effects, and manage anticoagulation carefully throughout the pregnancy to minimize risks to both mother and fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-287.jpg\" alt=\"\" width=\"600\" height=\"667\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Algorithm for management of women with prosthetic heart valves requiring anti-coagulation in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 2406</strong></span></p>",
      "correct_choice_id": 23243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5907,
      "choices": [
        {
          "id": 23598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management</span></span></span></p>"
        },
        {
          "id": 23599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up with beta-hCG</span></span></span></p>"
        },
        {
          "id": 23600,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction and evacuation</span></span></span></p>"
        },
        {
          "id": 23601,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with 12 weeks amenorrhea presents with vaginal bleeding. On examination, the cervical os is open and the uterus is 14 weeks size. USG shows a snowstorm appearance. The next best step in the management is?&nbsp;</span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q8136026",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585291,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Suction and evacuation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The snowstorm appearance on ultrasound is characteristic of a complete molar pregnancy (hydatidiform mole). Molar pregnancies are abnormal pregnancies where there is an overgrowth of trophoblastic tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete Molar Pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Presents with vaginal bleeding, an enlarged uterus greater than expected for gestational age, and a snowstorm appearance on ultrasound.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The primary treatment for a molar pregnancy is suction and evacuation to remove the abnormal trophoblastic tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-Evacuation Surveillance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> After evacuation, it is crucial to monitor beta-hCG levels to ensure complete removal of the molar tissue and to detect any possible malignancy (e.g., choriocarcinoma).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Medical management:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Medical management is not appropriate for molar pregnancy, as surgical evacuation is necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Follow up with beta-hCG:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta-hCG monitoring is essential after the initial treatment but not before the evacuation of the molar tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hysterectomy is not the first line of treatment for a molar pregnancy unless there are specific complications or risk factors warranting such an invasive procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of a molar pregnancy involves suction and evacuation to remove the abnormal trophoblastic tissue, followed by post-evacuation surveillance with beta-hCG levels to monitor for persistent gestational trophoblastic disease or malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s Textbook of obstetrics 26<sup>th</sup> edition pg 614</span></strong></span></span></p>",
      "correct_choice_id": 23600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6063,
      "choices": [
        {
          "id": 24222,
          "text": "<p><span style=\"font-size:12pt;\">Septate uterus</span></p>"
        },
        {
          "id": 24223,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Uterine didelphys</span></p>"
        },
        {
          "id": 24224,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Bicornuate uterus</span></p>"
        },
        {
          "id": 24225,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Unicornuate uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old woman is evaluated for primary infertility. Hysterosalpingography was done and reveals the finding shown below. What is the anomaly seen in the image?</span><span style=\"color:black;font-size:12.0pt;\">&nbsp;</span>(NEET PG 2022)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture6_g7vJDPm.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q5094220",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585300,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Septate uterus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The anomaly seen in the given hysterosalpingogram is suggestive of a septate uterus.</span></li><li><span style=\"font-size:12pt;\">A septate uterus is characterized by the presence of a septum in the endometrial cavity which hasn’t disappeared after fusion of the 2 Mullerian ducts</span></li><li><span style=\"font-size:12pt;\">On HSG, a septate and bicornuate uterus are commonly mis-diagnosed</span></li><li><span style=\"font-size:12pt;\">If the angle between the 2 horns is &lt;75, it is likely a septate uterus (As in this question)</span></li><li><span style=\"font-size:12pt;\">If the angle between the 2 horns is &gt;105, then it is likely a bicornuate uterus</span></li><li><span style=\"font-size:12pt;\">However, an HSG is not the ideal ix of choice</span></li><li><span style=\"font-size:12pt;\">An MRI is the best Ix for Mullerian anomalies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Uterine didelphys</strong>: Uterine didelphys appears as 2 completely separate uterine cavities on the HSG with no communication whatsoever</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-81.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bicornuate uterus</strong>: Bicornuate uterus: This appears as 2 horns of the uterus which are widely separated (angle &gt; 105<sup> </sup>degree)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-82.jpg\" alt=\"\" width=\"300\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Unicornuate uterus</strong>: Unicornuate uterus: Single horn on the HSG</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-83.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YJRdwGC.png\" width=\"639\" height=\"283\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The anomaly seen in the image is a septate uterus which&nbsp;</strong>is characterized by the presence of a septum in the endometrial cavity which hasn’t disappeared after fusion of the 2 Mullerian ducts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 47, DC Dutta’s Textbook of Gyn 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5800,
      "choices": [
        {
          "id": 23171,
          "text": "<p><span style=\"font-size:12pt;\">FSH</span></p>"
        },
        {
          "id": 23172,
          "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
        },
        {
          "id": 23173,
          "text": "<p><span style=\"font-size:12pt;\">LH</span></p>"
        },
        {
          "id": 23174,
          "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following hormones will be secreted in high amounts by the ovarian granulosa cells during the follicular phase of the menstrual cycle?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q5442340",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585297,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Estrogen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, the granulosa cells of the developing follicles secrete high amounts of estrogen, specifically estradiol. This phase is characterized by the development of a primordial follicle to the Graafian stage, with atresia of neighboring follicles. The following events occur during this phase:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Estrogen Secretion:</strong> Granulosa cells secrete increasing amounts of estrogen, primarily estradiol, which causes proliferation of the endometrium in preparation for potential implantation.</span></li><li><span style=\"font-size:12pt;\"><strong>Up-regulation of Receptors:</strong> LH and FSH receptors are up-regulated in both theca and granulosa cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Feedback Mechanism:</strong> The rising estradiol levels exert a negative feedback effect on the anterior pituitary, suppressing the secretion of FSH and LH to moderate levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. FSH (Follicle Stimulating Hormone):</strong> FSH is secreted by the anterior pituitary gland and stimulates the growth of ovarian follicles but is not secreted by granulosa cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LH (Luteinizing Hormone):</strong> LH is also secreted by the anterior pituitary and plays a role in the later stages of follicle development and ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Progesterone:</strong> Progesterone is primarily secreted by the corpus luteum after ovulation during the luteal phase of the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, ovarian granulosa cells secrete high amounts of estrogen, which is crucial for the proliferation of the endometrium and regulation of FSH and LH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 78, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5930,
      "choices": [
        {
          "id": 23690,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 23691,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 23692,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 23693,
          "text": "<p><span style=\"font-size:12.0pt;\">0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida is in labour. Her per-vaginal examination revealed a posterior cervix with 5 cm cervical length, 1 cm dilatation, soft consistency, and head at -1 station. Calculate the modified Bishop score?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q3203291",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585298,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Bishop Score</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The 5 components of the Modified Bishop score are:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Cervical Dilatation</span></li><li><span style=\"font-size:12.0pt;\">Cervical length</span></li><li><span style=\"font-size:12.0pt;\">Cervical consistency</span></li><li><span style=\"font-size:12.0pt;\">Cervical Position</span></li><li><span style=\"font-size:12.0pt;\">Station of the presenting part</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Easy to remember Mnemonic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">B – Bishop</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I – Effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">S – Station of presenting part</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H – Hard/ soft (consistency)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">O – Os dilatation (cervical dilatation)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">P – Position of the cervix</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12.0pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12.0pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12.0pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-226_ZlB06tA.jpg\" alt=\"\" width=\"900\" height=\"473\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Modified Bishop score is used to assess the cervix's favorability for induction, and a score of 5 in this context would be based on specific factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5817,
      "choices": [
        {
          "id": 23238,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic sonography</span></span></span></p>"
        },
        {
          "id": 23239,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterosalpingography</span></span></span></p>"
        },
        {
          "id": 23240,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial Biopsy</span></span></span></p>"
        },
        {
          "id": 23241,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotyping of the parents</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A female comes to Gynecology OPD for pre-conceptual counseling, with 2 prior second trimester abortions. What is the next investigation you will advise?&nbsp;</span></span>(INICET NOV 2018)</p>",
      "unique_key": "Q9009396",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585308,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pelvic sonography</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common cause of recurrent second trimester pregnancy loss (RPL) is anatomical abnormalities of the uterus. The initial investigation for anatomical abnormalities is a transvaginal ultrasound (pelvic sonography) as it is non-invasive and provides detailed imaging of the uterine structure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent first trimester abortions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Often associated with antiphospholipid antibody syndrome (APLA) or endocrinological causes.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent second trimester abortions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Often associated with anatomical uterine problems.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single spontaneous abortion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Most commonly caused by fetal genetic abnormalities.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hysterosalpingography:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is not routinely advised for anatomical abnormalities of the uterus. It is more commonly used for evaluating tubal patency and uterine cavity shape but is not the first-line investigation in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Endometrial Biopsy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is advised in women with suspected genital tuberculosis or in women with suspected luteal phase defect. It is not typically indicated for recurrent second trimester pregnancy loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Karyotyping of the parents:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Chromosomal abnormalities, such as balanced translocations, account for only about 5% of recurrent pregnancy loss (RPL). Therefore, parental karyotyping is not an initial investigation of choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The initial investigation for recurrent second trimester pregnancy loss (RPL) is pelvic sonography to evaluate for anatomical abnormalities of the uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 2<sup>t6h</sup> edition pg 203</span></strong></span></span></p>",
      "correct_choice_id": 23238,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47248,
      "choices": [
        {
          "id": 188603,
          "text": "<p><span style=\"font-size:12.0pt;\">hCG</span></p>"
        },
        {
          "id": 188604,
          "text": "<p><span style=\"font-size:12.0pt;\">LH</span></p>"
        },
        {
          "id": 188605,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 188606,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which hormone is increased in the condition shown in the image?&nbsp; </span>(FMGE JULY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-170405.png\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q1201821",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585283,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) hCG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts the classic <strong>\"snowstorm\" appearance</strong> seen on ultrasound, which is characteristic of a <strong>molar pregnancy</strong>, specifically a <strong>complete mole</strong>. In a complete molar pregnancy, there is abnormal trophoblastic proliferation and hydropic degeneration of chorionic villi, leading to the absence of fetal tissue and the characteristic ultrasound appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The key hormone that is markedly elevated in molar pregnancy is <strong>human chorionic gonadotropin (hCG)</strong>. This hormone is produced in excessive amounts due to the trophoblastic proliferation. The extremely high levels of hCG are responsible for many of the symptoms and complications associated with molar pregnancies, such as hyperemesis gravidarum, early-onset preeclampsia, and ovarian theca-lutein cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. LH (Luteinizing Hormone)</strong>: This hormone is involved in the regulation of the menstrual cycle and ovulation but is not specifically elevated in molar pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Estrogen</strong>: Levels of estrogen can be altered in pregnancy and other conditions but are not specifically elevated in molar pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Progesterone</strong>: This hormone supports pregnancy, but its levels are not specifically elevated due to molar pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hormone significantly elevated in molar pregnancy, as indicated by the ultrasound image showing a \"snowstorm\" appearance, is human chorionic gonadotropin (hCG).</span></p>",
      "correct_choice_id": 188603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5999,
      "choices": [
        {
          "id": 23966,
          "text": "<p><span style=\"font-size:12pt;\">2, 4</span></p>"
        },
        {
          "id": 23967,
          "text": "<p><span style=\"font-size:12pt;\">1, 2</span></p>"
        },
        {
          "id": 23968,
          "text": "<p><span style=\"font-size:12pt;\">1, 3</span></p>"
        },
        {
          "id": 23969,
          "text": "<p><span style=\"font-size:12pt;\">2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following investigations is used to diagnose unicornuate uterus?&nbsp;</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Falloposcopy</span></li><li><span style=\"font-size:12pt;\">Laparoscopy</span></li><li><span style=\"font-size:12pt;\">HSG</span></li><li><span style=\"font-size:12pt;\">X-ray</span></li></ol>",
      "unique_key": "Q8547666",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585327,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Laparoscopy:</strong> This is a minimally invasive surgical procedure that allows direct visualization of the pelvic organs, including the uterus. It is effective in diagnosing structural anomalies like a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. HSG (Hysterosalpingogram):</strong> This is an X-ray procedure where a contrast dye is injected into the uterine cavity and fallopian tubes. It helps in visualizing the shape of the uterine cavity and the patency of the fallopian tubes, making it useful in diagnosing a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 2, 4:</strong> While laparoscopy (2) is correct, X-ray (4) alone is not specific or detailed enough to diagnose a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 1, 2:</strong> Falloposcopy (1) is used to visualize the interior of the fallopian tubes, not to diagnose uterine anomalies. Laparoscopy (2) is correct but falloposcopy is not appropriate for this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 1, 3:</strong> Similar to option B, falloposcopy (1) is not relevant for diagnosing uterine anomalies, even though HSG (3) is correct.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Falloposcopy:</strong> Refers to the visualization of the interior of the fallopian tube lumen and tubal ostia using a flexible fiber optic device via hysteroscope.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis of Mullerian Anomalies:</strong> Can be achieved through various methods, including:</span><ol><li><span style=\"font-size:12pt;\">Ultrasound (Preferably 3D USG)</span></li><li><span style=\"font-size:12pt;\">MRI (Investigation of choice)</span></li><li><span style=\"font-size:12pt;\">HSG</span></li><li><span style=\"font-size:12pt;\">Hystero-laparoscopy</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopy and HSG are effective diagnostic tools for identifying unicornuate uterus and other Mullerian anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 47, William’s textbook of gynecology 3<sup>rd</sup> edition pg418</strong></span></p>",
      "correct_choice_id": 23969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44010,
      "choices": [
        {
          "id": 175699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remove placenta and reposition the uterus</span></span></span></p>"
        },
        {
          "id": 175700,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Put uterus inside without removing the placenta</span></span></span></p>"
        },
        {
          "id": 175701,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shift to OT and insert the uterus back</span></span></span></p>"
        },
        {
          "id": 175702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has just delivered a full-term baby and developed uterine inversion with the placenta still attached. What is the immediate next step?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q3668794",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Put uterus inside without removing the placenta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate management of uterine inversion involves repositioning the uterus before removing the placenta to prevent severe bleeding and shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Remove placenta and reposition the uterus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Removing the placenta before repositioning the uterus can lead to massive hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Shift to OT and insert the uterus back:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immediate manual repositioning is crucial before shifting to an operating theatre.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start Oxytocin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxytocin is used after the uterus is repositioned to encourage contraction, not before.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of uterine inversion, the uterus should be repositioned with the placenta still attached to avoid significant bleeding, followed by medical management for uterine contraction.</span></span></span></p>",
      "correct_choice_id": 175700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56843,
      "choices": [
        {
          "id": 226765,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">48hrs</span></span></p>"
        },
        {
          "id": 226766,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">48hrs &ndash; 6 weeks</span></span></p>"
        },
        {
          "id": 226767,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24hrs</span></span></p>"
        },
        {
          "id": 226768,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12hrs</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IUCD can be inserted after delivery till? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q2679590",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>A) 48hrs</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An Intrauterine Contraceptive Device (IUCD), specifically the Copper T, can be inserted immediately after delivery as part of postpartum family planning. The optimal time frames for insertion include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Post-placental insertion:</span></strong><span style=\"font-size:12.0pt\"> Within 10 minutes of placental delivery, commonly done when the patient is highly motivated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Early postpartum insertion:</span></strong><span style=\"font-size:12.0pt\"> From 10 minutes up to 48 hours after delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intra-caesarean insertion:</span></strong><span style=\"font-size:12.0pt\"> At the time of cesarean section.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Late postpartum </span></strong><span style=\"font-size:12.0pt\">&ndash; After 6 weeks&nbsp; </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early postpartum IUCD insertion is considered safe and effective during this period due to the lower risk of expulsion and higher motivation of the patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note -&nbsp; 48hrs to 6 weeks&rsquo;&nbsp;</span></strong><span style=\"font-size:12.0pt\">period is not suitable for IUCD insertion due to the high risk of expulsion and complications as the uterus is actively involuting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IUCD can be inserted within 48 hours of delivery, but not between 48 hours to 6 weeks due to the high risk of expulsion during this time.</span></span></span></p>",
      "correct_choice_id": 226765,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54777,
      "choices": [
        {
          "id": 218573,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 12 mg 24 hourly 2 doses</span></span></p>"
        },
        {
          "id": 218574,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></span></p>"
        },
        {
          "id": 218575,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 12 hourly 2 doses</span></span></p>"
        },
        {
          "id": 218576,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 24 hourly 4 doses</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the dose of corticosteroids for lung maturity? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q1790598",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585281,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Dexamethasone 6 mg 12 hourly 4 doses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are administered to pregnant women who are at risk of preterm delivery (before 34 weeks of gestation) to enhance fetal lung maturity and reduce the risk of neonatal respiratory distress syndrome. The correct dosing regimen for corticosteroids is crucial for their effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">and <strong>Betamethasone</strong> are the two corticosteroids commonly used for this purpose:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is given as 6 mg intramuscularly every 12 hours, totaling four doses. This regimen ensures adequate fetal lung maturation by delivering consistent steroid levels over 48 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Betamethasone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is typically administered as 12 mg intramuscularly, given in two doses 24 hours apart. This regimen also effectively promotes fetal lung maturity but involves fewer doses compared to Dexamethasone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In this specific case, the correct answer is <strong>Dexamethasone 6 mg 12 hourly 4 doses</strong> because it follows the standard protocol for promoting lung maturity in fetuses at risk of preterm birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For fetal lung maturity, the standard dosing regimen of Dexamethasone is 6 mg intramuscularly every 12 hours for a total of 4 doses. This regimen is effective in reducing the risk of neonatal respiratory distress syndrome in preterm infants.</span></span></span></p>",
      "correct_choice_id": 218574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5861,
      "choices": [
        {
          "id": 23414,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian hyperstimulation syndrome</span></p>"
        },
        {
          "id": 23415,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Theca lutein cyst</span></p>"
        },
        {
          "id": 23416,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Polycystic ovarian syndrome</span></p>"
        },
        {
          "id": 23417,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿None</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with a history of infertility is on treatment with human gonadotropin. She presented with the following finding in the USG. What is the most likely diagnosis?&nbsp;(</span>NEET PG 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture3.jpg\" alt=\"\" width=\"300\" height=\"160\"></span></p>",
      "unique_key": "Q6621601",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585322,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Ovarian hyperstimulation syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image is a transvaginal ultrasound showing the ovaries which appear significantly enlarged with fluid in the pelvic cavity (the black spaces seen in between the ovaries)</span></li><li><span style=\"font-size:12pt;\">In view of her history of controlled ovarian hyperstimulation in IVF, the answer is OHSS</span><ul><li><span style=\"font-size:12pt;\">Ovarian hyperstimulation syndrome is characterized by multiple ovarian follicular cysts accompanied by increased capillary permeability and leakage of intravascular fluid to the third space.</span></li><li><span style=\"font-size:12pt;\">It is commonly seen after exogenous administration of FSH, LH or HCG injections.</span></li><li><span style=\"font-size:12pt;\">Multiple enlarged follicles are arranged in a necklace pattern in bilateral ovaries.</span></li><li><span style=\"font-size:12pt;\">The mainstay of management is conservative. The ongoing stimulation cycle is suspended, and further administration of exogenous gonadotropins are stopped in that cycle.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Theca lutein cysts</strong>: Enlarged cysts seen in molar pregnancy, not related to the provided scenario or ultrasound findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Polycystic ovarian syndrome (PCOS)</strong>: PCOS is a risk factor for OHSS, but given the history and the ultrasound image, OHSS is the more appropriate answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">OHSS is characterized by multiple enlarged ovarian follicles and fluid accumulation in the pelvic cavity, often occurring after exogenous gonadotropin administration in infertility treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 456, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 23414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5687,
      "choices": [
        {
          "id": 22720,
          "text": "<p><span style=\"font-size:12pt;\">5 cm</span></p>"
        },
        {
          "id": 22721,
          "text": "<p><span style=\"font-size:12pt;\">8 cm</span></p>"
        },
        {
          "id": 22722,
          "text": "<p><span style=\"font-size:12pt;\">4 cm</span></p>"
        },
        {
          "id": 22723,
          "text": "<p><span style=\"font-size:12pt;\">6 cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the latest labour care guidelines, the partogram is plotted in regular intervals after _ cm dilatation:&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q2266234",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585303,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 5 cm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Earlier, in the WHO modified partograph, labor is graphed and analysis includes use of action lines and alert lines.</span></li><li><span style=\"font-size:12pt;\">In this partograph, the plotting starts in active phase (4cm)</span></li><li><span style=\"font-size:12pt;\">The alert line is plotted at a cervical dilatation rate of 1cm/h</span></li><li><span style=\"font-size:12pt;\">The action line is plotted 4h to the right of the alert line</span></li><li><span style=\"background-color:transparent;font-size:12pt;\">&nbsp;The 1st marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">The WHO modified partograph has now been replaced by the WHO labor care guide where the new definition of active labor is 5 cm</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F6uAbxo.png\" width=\"1337\" height=\"340\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As per the WHO modified partograph, plotting is started at 4cm cervical dilatation, and the 1<sup>st</sup> marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">As per the Labor Care Guide, plotting is started at 5 cm cervical dilatation</span></li></ul>",
      "correct_choice_id": 22720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5752,
      "choices": [
        {
          "id": 22979,
          "text": "<p><span style=\"font-size:12pt;\">September 19</span></p>"
        },
        {
          "id": 22980,
          "text": "<p><span style=\"font-size:12pt;\">October 19</span></p>"
        },
        {
          "id": 22981,
          "text": "<p><span style=\"font-size:12pt;\">October 16</span></p>"
        },
        {
          "id": 22982,
          "text": "<p><span style=\"font-size:12pt;\">September 16</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman whose obstetric score is G2 P1 L1 had an LMP of Jan 9th 2017. Calculate the EDD according to Naegele's rule?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q8800268",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585280,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) October 16</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Normal duration of pregnancy: 280 days (40 weeks)</span></li><li><span style=\"font-size:12pt;\">Calculating the EDD: <strong>Naegele’s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Add 9 months + 7 days</span></li><li><span style=\"font-size:12pt;\">Subtract 3 months and add 7 days</span></li><li><span style=\"font-size:12pt;\">For IVF Pregnancies: add 9 months and subtract 7 days from the date of the embryo transfer</span></li></ul></li><li><span style=\"font-size:12pt;\">For e.g. The EDD of this patient will be 16/10/2017.</span></li><li><span style=\"font-size:12pt;\"><strong>Dating the pregnancy:</strong> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">1st trimester CRL: most accurate (till 14 weeks)</span></li><li><span style=\"font-size:12pt;\">BPD in the 2nd trimester</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Naegele's rule is a standard way of calculating the estimated date of delivery by adding 9 months and 7 days to the first day of the last menstrual period. This method assumes a regular 28-day menstrual cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 83, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5799,
      "choices": [
        {
          "id": 23167,
          "text": "<p><span style=\"font-size:12pt;\">Increased number of theca lutein cysts</span></p>"
        },
        {
          "id": 23168,
          "text": "<p><span style=\"font-size:12pt;\">Persistently enlarged uterus</span></p>"
        },
        {
          "id": 23169,
          "text": "<p><span style=\"font-size:12pt;\">Plateau of high serum hCG</span></p>"
        },
        {
          "id": 23170,
          "text": "<p><span style=\"font-size:12pt;\">Sub-urethral nodule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following can be indicators of choriocarcinoma except:&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4698835",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585296,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Increased number of theca lutein cysts</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Choriocarcinoma is a malignant form of gestational trophoblastic neoplasia (GTN) that arises from trophoblastic tissue following a molar pregnancy, miscarriage, abortion, or normal pregnancy. Indicators of choriocarcinoma include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Persistently enlarged uterus:</strong> Indicates continued trophoblastic proliferation.</span></li><li><span style=\"font-size:12pt;\"><strong>Plateau of high serum hCG:</strong> Persistent high levels of hCG after treatment suggest ongoing trophoblastic disease.</span></li><li><span style=\"font-size:12pt;\"><strong>Sub-urethral nodule:</strong> A rare but specific sign of metastatic choriocarcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of theca lutein cysts alone is not a specific indicator of choriocarcinoma, though these cysts can persist in cases of GTN. The increased number of theca lutein cysts is associated with molar pregnancies and persistent GTN but not specifically indicative of choriocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Persistently enlarged uterus:</strong> This is a common finding in choriocarcinoma due to persistent trophoblastic tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Plateau of high serum hCG:</strong> This is a hallmark of choriocarcinoma as it indicates continued activity of the trophoblastic cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sub-urethral nodule:</strong> This can be a sign of metastasis from choriocarcinoma. Indicates metastasis of choriocarcinoma forming a firm palpable mass beneath urethral nodule</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indicators of choriocarcinoma include persistently enlarged uterus, plateau of high serum hCG, and sub-urethral nodules, but not an increased number of theca lutein cysts alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 361, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20489,
      "choices": [
        {
          "id": 81918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydial infection</span></span></span></p>"
        },
        {
          "id": 81919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscess</span></span></span></p>"
        },
        {
          "id": 81920,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genital Tuberculosis</span></span></span></p>"
        },
        {
          "id": 81921,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes with complaints of pain and swelling in the perineal area, difficulty in walking and sitting. She has a history of multiple sexual partners. On examination, a tender swelling is seen with redness on the labia, as shown in the image given below. What is the most likely diagnosis?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210148.jpg\" style=\"height:347px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8813056",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585278,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bartholin abscess</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical scenario and image points to the diagnosis of Bartholin&#39;s abscess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin Cyst and Abscess</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland is a mucus-secreting gland, which plays a role in vaginal lubrication. They are a pair of 0.5 cm glands located in the lower right and left portions at the 4 o&rsquo;clock and 8 o&rsquo;clock positions of the vaginal introitus. They are generally nonpalpable when not obstructed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathophysiology: Bartholin glands can form a cyst and an abscess in women of reproductive age and may cause dyspareunia, urinary irritation, and vague pelvic pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The physical exam will often reveal asymmetry with a protrusion of one side (left or right) of the inferior aspect of the vulva.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland abscesses, unlike Bartholin cysts, are very painful.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While both are primarily unilateral, Bartholin abscesses are often tender to palpation, erythematous, indurated, and may have an area of fluctuance and/or purulent drainage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic Bartholin cysts do not require further treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscesses may be treated with incision and drainage with Word catheter placement due to ease and effectiveness of treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marsupialization is the procedure of choice.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with recurrent cysts or those who are post-menopausal (risk of malignancy) should have the cyst completely excised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chlamydial infection</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chlamydial infection patient usually present with vaginal discharge, dysuria, or cervicitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Genital tuberculosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital tuberculosis involves the upper genital tract, leading to menstrual irregularities, infertility, and abdominal pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Genital herpes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital herpes usually presents as painful ulcers or vesicles in the genital area, rather than a tender, erythematous swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Bartholin abscess presents with significant pain, redness, and swelling in the labia, often making walking and sitting difficult.</span></span></span></p>",
      "correct_choice_id": 81919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23226,
      "choices": [
        {
          "id": 92868,
          "text": "<p><span style=\"font-size:12pt;\">Uterine torsion</span></p>"
        },
        {
          "id": 92869,
          "text": "<p><span style=\"font-size:12pt;\">Infection of fibroid</span></p>"
        },
        {
          "id": 92870,
          "text": "<p><span style=\"font-size:12pt;\">Red degeneration of fibroid</span></p>"
        },
        {
          "id": 92871,
          "text": "<p><span style=\"font-size:12pt;\">Preterm labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 28 weeks of gestation is experiencing symptoms of fever, acute abdominal pain, and a slight increase in white blood cell count. What is the most likely diagnosis?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q7064192",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585306,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Red degeneration of fibroid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>RED DEGENERATION OF FIBROID</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Occurs in a large fibroid mainly during second half of pregnancy and puerperium.</span></li><li><span style=\"font-size:12pt;\">The cause is not known but is probably due to thrombosis and infarction</span></li><li><span style=\"font-size:12pt;\">The typical presentation is severe abdominal pain especially in the 2nd trimester of pregnancy.</span></li><li><span style=\"font-size:12pt;\">Treatment is symptomatic with analgesics and hydration</span></li><li><span style=\"font-size:12pt;\">TLC is raised but the etiology is not infective</span></li><li><span style=\"font-size:12pt;\"><strong>Surgery is NOT done for red degeneration</strong></span></li><li><span style=\"font-size:12pt;\">Can also happen in the puerperium and in women on combined OCPS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Uterine torsion</strong>: Uterine torsion can lead to birth obstruction, abdominal pain, vaginal bleeding, shock, and urinary and intestinal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Infection of fibroid</strong>: Infection of fibroid can cause blood-stained purulent discharge</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Preterm labor</strong>: Preterm labor doesn’t relate with fever, raised TLC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Red degeneration of fibroid, which typically occurs in the second half of pregnancy or puerperium, presents with severe abdominal pain, fever, and a slight increase in white blood cell count. It is caused by thrombosis and infarction of the fibroid, and treatment is symptomatic with analgesics and hydration. Surgery is not performed for red degeneration.</span></p>",
      "correct_choice_id": 92870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47890,
      "choices": [
        {
          "id": 191155,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral labetalol</span></p>"
        },
        {
          "id": 191156,
          "text": "<p><span style=\"font-size:12.0pt;\">IV labetalol</span></p>"
        },
        {
          "id": 191157,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 191158,
          "text": "<p><span style=\"font-size:12.0pt;\">Telmisartan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the antihypertensive of choice in a 28-week preeclamptic woman with asthma?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q4338174",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585286,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nifedipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In managing preeclampsia, labetalol is often the first-line antihypertensive due to its efficacy and safety profile in pregnancy. However, labetalol is both an alpha and beta-blocker, and its use can exacerbate asthma by causing bronchoconstriction. Therefore, it is contraindicated in asthmatic patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nifedipine: This is a calcium channel blocker that is safe and effective in pregnancy. It does not have the bronchoconstrictive effects of labetalol, making it the antihypertensive of choice for a preeclamptic woman with asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oral labetalol and Option B. IV labetalol:&nbsp;</strong>Both forms are contraindicated in patients with asthma due to the risk of bronchoconstriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Telmisartan:&nbsp;</strong>This angiotensin receptor blocker (ARB) is contraindicated in pregnancy because it can cause fetal renal hypoperfusion and oligohydramnios, among other teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nifedipine is the antihypertensive of choice in a preeclamptic woman with asthma due to its safety profile and lack of broncho constrictive effects.</span></p>",
      "correct_choice_id": 191157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20487,
      "choices": [
        {
          "id": 81910,
          "text": "<p><span style=\"font-size:12pt;\">Oral methotrexate</span></p>"
        },
        {
          "id": 81911,
          "text": "<p><span style=\"font-size:12pt;\">Single-dose methotrexate injection</span></p>"
        },
        {
          "id": 81912,
          "text": "<p><span style=\"font-size:12pt;\">Serial methotrexate + leucovorin rescue</span></p>"
        },
        {
          "id": 81913,
          "text": "<p><span style=\"font-size:12pt;\">Salpingectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents to OPD with 6 weeks of amenorrhea complaints of bleeding per vagina and mild abdominal pain. The urine pregnancy test is positive and hCG level is 2800 IU/L. On investigation, mass is seen on the left adnexa measuring 3 x 2 cm. She is hemodynamically stable. How will you manage this patient?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q8338569",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585277,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Single-dose methotrexate injection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario presented indicates an unruptured ectopic pregnancy. The patient is hemodynamically stable, and the hCG level is 2800 IU/L with an adnexal mass measuring 3 x 2 cm. These findings meet the criteria for medical management of an ectopic pregnancy with methotrexate. Single-dose methotrexate injection is an appropriate treatment choice for an unruptured ectopic pregnancy when the patient is stable, has no significant symptoms, and the gestational sac is less than 3.5 cm in size without visible cardiac activity. Methotrexate is a folic acid antagonist that inhibits DNA synthesis and cell replication, effectively treating the ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Oral methotrexate:</strong> Oral methotrexate is not a standard treatment protocol for ectopic pregnancy. Methotrexate for ectopic pregnancy is typically administered via injection to ensure proper dosage and effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Serial methotrexate + leucovorin rescue:</strong> This multidose protocol is used for ectopic pregnancies with higher hCG levels or when the single-dose protocol is contraindicated or has failed. However, it is more complex and involves multiple injections and monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Salpingectomy:</strong> Surgical management, such as salpingectomy, is indicated for ectopic pregnancies with significant pain, adnexal masses larger than 35 mm, visible fetal heartbeat, or serum hCG levels of 5000 IU/L or more. In this case, the patient’s condition does not meet these criteria, making surgery unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of Unruptured Ectopic</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180854.png\" alt=\"\" width=\"1000\" height=\"577\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Surgical Management in Unruptured Ectopic –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indicated in:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12pt;\">an ectopic pregnancy and significant pain</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with an adnexal mass of 35 mm or larger</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with a fetal heartbeat visible on an ultrasound scan</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy and a serum hCG level of 5,000 IU/L or more</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">&nbsp;Laparoscopy is preferred</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">SALPINGECTOMY: Preferred if:</span><ul><li><span style=\"font-size:12pt;\">Extensive tubal involvement/ damage</span></li><li><span style=\"font-size:12pt;\">Recurrent ectopic pregnancy in the same tube</span></li><li><span style=\"font-size:12pt;\">Completed family</span></li><li><span style=\"font-size:12pt;\">Ectopic at the site of a previous tubal sterilization</span></li></ul></li><li><span style=\"font-size:12pt;\">SALPINGOSTOMY: (Linear incision on the antimesenteric border with removal of products of conception) Done if a woman wants to conceive in the future.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of an unruptured ectopic pregnancy in a hemodynamically stable patient with an hCG level less than 5000 IU/L and an adnexal mass smaller than 3.5 cm is typically treated with a single-dose methotrexate injection.</span></p>",
      "correct_choice_id": 81911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5876,
      "choices": [
        {
          "id": 23474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 23475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 23476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">13 to 20 weeks</span></span></span></p>"
        },
        {
          "id": 23477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 to 28 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risk of fetal varicella syndrome is maximum when the mother is infected between:&nbsp;</span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q1066006",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585330,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 13 to 20 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Varicella Zoster Virus (VZV) is a double-stranded DNA virus that is primarily acquired in childhood and causes chickenpox. The virus is transmitted through direct contact with an infected individual. Nonimmune pregnant women who come into close contact with a patient with chickenpox are at risk of contracting the infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a pregnant woman contracts chickenpox, particularly early in pregnancy, there is a risk of congenital varicella syndrome in the fetus. The highest risk period for the development of congenital varicella syndrome is between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital varicella syndrome includes the following features:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorioretinitis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microphthalmia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebral cortical atrophy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal growth restriction</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydronephrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Limb hypoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cicatricial skin lesions</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the fetus or neonate is exposed to active VZV infection just before or during delivery (less than 5 days before and up to 2 days after delivery), there is a significant risk of disseminated disease and CNS involvement in the neonate, with a mortality rate of approximately 30%. In such cases, administration of VZIG (Varicella-Zoster Immune Globulin) is recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The highest risk period for the development of congenital varicella syndrome in a fetus is when the mother is infected with Varicella Zoster Virus between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 3085</span></strong></span></span></p>",
      "correct_choice_id": 23476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5906,
      "choices": [
        {
          "id": 23594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG- IUCD</span></span></span></p>"
        },
        {
          "id": 23595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">POP for 3 months</span></span></span></p>"
        },
        {
          "id": 23596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 23597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial sampling</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman presents with abnormal uterine bleeding for two months. What is the next line of management?&nbsp;</span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q9571089",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585289,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Endometrial sampling</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The next line of management in a 50-year-old woman with abnormal uterine bleeding (AUB) is an endometrial biopsy. This is crucial to rule out endometrial hyperplasia or malignancy, especially in a peri-menopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for Endometrial Sampling:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peri-menopausal women with AUB.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperestrogenic states like obesity or tamoxifen treatment with thickened endometrium on transvaginal sonography (TVS).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with failed medical management and persistent bleeding.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transvaginal ultrasound findings of endometrial thickness &gt;12 mm in premenopausal women and &gt;4 mm in postmenopausal women.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methods of Endometrial Sampling:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Curettage</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspiration biopsy using Pipelle or Vibra aspirator</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. LNG-IUCD:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Levonorgestrel intrauterine device (LNG-IUCD) is a treatment option but should be considered after ruling out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. POP for 3 months:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Progestin-only pills (POP) can be used to manage AUB, but endometrial sampling should be done first to rule out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hysterectomy is a definitive treatment but is considered after other management options and ruling out malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In peri-menopausal women presenting with abnormal uterine bleeding, the first step is to perform endometrial sampling to rule out endometrial hyperplasia or malignancy before considering other treatment modalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of gynecology 3<sup>rd </sup>edition Pg184</span></strong></span></span></p>",
      "correct_choice_id": 23597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55315,
      "choices": [
        {
          "id": 220721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non vigorous baby</span></span></span></p>"
        },
        {
          "id": 220722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rh negative mother</span></span></span></p>"
        },
        {
          "id": 220723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preterm</span></span></span></p>"
        },
        {
          "id": 220724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pre-eclampsia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When should early cord clamping be done? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q2481079",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585287,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Non vigorous baby</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Early cord clamping should be done primarily when the baby is non-vigorous</span><span style=\"font-size:12.0pt\">/</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> hypoxic</span><span style=\"font-size:12.0pt\"> baby i.e. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">not breathing, or not crying at birth. Immediate neonatal resuscitation is required in such cases to address the baby&#39;s urgent need for oxygen and support. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Delaying cord clamping in a non-vigorous baby could waste crucial time needed for resuscitation efforts. According to WHO guidelines, the only absolute contraindication to delayed cord clamping is a non-vigorous baby.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Rh negative mother</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Although older guidelines suggested early cord clamping in Rh-negative mothers to reduce the risk of fetomaternal hemorrhage, current guidelines do not strongly recommend this practice. The benefits of delayed cord clamping, such as reducing anemia in the baby, outweigh the potential risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Preterm</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: For preterm babies, delayed cord clamping is recommended to help prevent anemia and improve blood volume. Preterm infants benefit significantly from the additional blood received during delayed clamping.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Pre-eclampsia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Pre-eclampsia is not a contraindication for delayed cord clamping. Delayed clamping can still provide the newborn with additional blood and help prevent anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Early cord clamping is indicated for non-vigorous babies who require immediate resuscitation efforts.</span></span></span></p>",
      "correct_choice_id": 220721,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5967,
      "choices": [
        {
          "id": 23838,
          "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
        },
        {
          "id": 23839,
          "text": "<p><span style=\"font-size:12pt;\">Antiphospholipid antibody syndrome</span></p>"
        },
        {
          "id": 23840,
          "text": "<p><span style=\"font-size:12pt;\">TORCH infections</span></p>"
        },
        {
          "id": 23841,
          "text": "<p><span style=\"font-size:12pt;\">Gestational diabetes mellitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old G4A3 woman had a history of miscarriage at 8 weeks, the second miscarriage at 11 weeks with no cardiac activity, and the third pregnancy loss at 24 weeks with preterm delivery due to early-onset preeclampsia. What is the most probable diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q4374771",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585314,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Antiphospholipid antibody syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Antiphospholipid antibody syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The patient's history of recurrent pregnancy loss (RPL) and a pregnancy complicated by early-onset preeclampsia is highly suggestive of Antiphospholipid Antibody Syndrome (APLA).</span></li><li><span style=\"font-size:12pt;\">APLA is diagnosed based on clinical and laboratory criteria. The clinical criteria include obstetric complications such as unexplained fetal death, severe preeclampsia necessitating early delivery, and recurrent early pregnancy losses. Vascular thrombosis is also a clinical criterion.</span></li><li><span style=\"font-size:12pt;\">Laboratory criteria include the presence of lupus anticoagulant, medium to high titers of anticardiolipin antibodies, and anti-β2 glycoprotein antibodies. These must be present on two or more occasions at least 12 weeks apart.</span></li><li><span style=\"font-size:12pt;\">The Sapporo Criteria for diagnosing APLA require at least one clinical and one laboratory criterion to be present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Syphilis:</strong> Although syphilis can cause adverse pregnancy outcomes, including miscarriage and stillbirth, it is less likely than APLA to cause the combination of early pregnancy loss and early-onset preeclampsia described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. TORCH infections:&nbsp;</strong>TORCH infections (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, and Herpes simplex virus) can lead to congenital anomalies, intrauterine growth restriction, and pregnancy loss. However, recurrent pregnancy loss due to TORCH infections is rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Gestational diabetes mellitus:&nbsp;</strong>Gestational diabetes mellitus (GDM) typically affects pregnancies later in gestation and is associated with macrosomia, neonatal hypoglycemia, and other complications, but it is not commonly associated with recurrent pregnancy loss or early-onset preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Antiphospholipid antibody syndrome is characterized by recurrent pregnancy loss and complications such as early-onset preeclampsia, necessitating early delivery. Diagnosis is based on the presence of clinical and laboratory criteria according to the Sapporo Criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2550, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23839,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47257,
      "choices": [
        {
          "id": 188639,
          "text": "<p><span style=\"font-size:12.0pt;\">Pinard maneuver</span></p>"
        },
        {
          "id": 188640,
          "text": "<p><span style=\"font-size:12.0pt;\">Lovset maneuver</span></p>"
        },
        {
          "id": 188641,
          "text": "<p><span style=\"font-size:12.0pt;\">Ritgen maneuver</span></p>"
        },
        {
          "id": 188642,
          "text": "<p><span style=\"font-size:12.0pt;\">Mauriceau maneuver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify this maneuver:&nbsp;</span>(FMGE JULY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-170927.png\" alt=\"\" width=\"300\" height=\"236\"></span></p>",
      "unique_key": "Q8265780",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585292,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ritgen maneuver</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts the Ritgen maneuver, which is performed during the second stage of labor to control the delivery of the fetal head. This maneuver involves <strong>controlled extension of the head</strong> to minimize perineal trauma. The pressure is applied on the fetal chin through the perineum while simultaneously controlling the speed of delivery of the head with the other hand.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This helps in a gradual delivery of the head, reducing the risk of severe perineal tears.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pinard maneuver</strong>: This maneuver is used during breech delivery to assist in delivering the legs by hooking them at the popliteal fossa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-171034.png\" alt=\"\" width=\"500\" height=\"466\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lovset maneuver</strong>: This is also used in breech delivery, specifically to help deliver the arms that are positioned over the head (nuchal arms).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-171127.png\" alt=\"\" width=\"500\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mauriceau maneuver</strong>: This is used for delivering the after-coming head in a breech presentation, involving the application of pressure on the maxilla and supporting the body of the baby to facilitate head delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-171224_XOiolpr.png\" alt=\"\" width=\"500\" height=\"361\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Ritgen maneuver involves controlled extension of the fetal head during delivery to minimize perineal trauma and ensure a smooth birth process.</span></p>",
      "correct_choice_id": 188641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5858,
      "choices": [
        {
          "id": 23402,
          "text": "<p><span style=\"font-size:12pt;\">Point B is 3 cm lateral to point A</span></p>"
        },
        {
          "id": 23403,
          "text": "<p><span style=\"font-size:12pt;\">Point A is 2 cm above the external os and 5 cm lateral to the internal uterine canal</span></p>"
        },
        {
          "id": 23404,
          "text": "<p><span style=\"font-size:12pt;\">Point A receives a dose of 7000 cGy</span></p>"
        },
        {
          "id": 23405,
          "text": "<p><span style=\"font-size:12pt;\">Point B receives a dose of 6000 cGy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman diagnosed with carcinoma cervix stage 2B was advised radiotherapy. Which of the following statements regarding radiotherapy is false?&nbsp;</span>(NEET PG 2020)</p>",
      "unique_key": "Q3865369",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585319,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Point A is 2 cm above the external os and 5 cm lateral to the internal uterine canal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Point A</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A point 2 cm lateral and 2 cm superior to the external cervical os.</span></li><li><span style=\"font-size:12pt;\">Represents the anatomical location of the ureter.</span></li><li><span style=\"font-size:12pt;\">The total dose to point A should not exceed 8000 cGy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Point B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A point 3 cm lateral to point A.</span></li><li><span style=\"font-size:12pt;\">Represents a dose to the pelvic wall.</span></li><li><span style=\"font-size:12pt;\">The dose to point B is about 25 – 30% of the dose to point A (4500 – 6500 cGy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>False Statement Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Point A is 2 cm above the external os and 5 cm lateral to the internal uterine canal</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">This statement is false because Point A is defined as 2 cm lateral and 2 cm superior to the external cervical os, not 5 cm lateral.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Point A in cervical cancer radiotherapy is located 2 cm lateral and 2 cm superior to the external cervical os, and the total dose should not exceed 8000 cGy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 350, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47857,
      "choices": [
        {
          "id": 191023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Motility &gt;32%</span></span></span></span></p>"
        },
        {
          "id": 191024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm count &gt; 20 million</span></span></span></span></p>"
        },
        {
          "id": 191025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphology &lt; 8%</span></span></span></span></p>"
        },
        {
          "id": 191026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm concentration &lt; 40 million/ml</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is true regarding normal semen parameters?&nbsp;(FMGE JANUARY 2024)</span></span></span></span></p>",
      "unique_key": "Q3533716",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585328,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Motility &gt;32%</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the recent guidelines on normal semen parameters, <strong>progressive motility should be more than 32%.</strong> This is an important indicator of sperm health and fertility potential. The motility of sperm refers to their ability to move efficiently, which is crucial for natural conception as the sperm must travel through the female reproductive tract to fertilize the egg.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The other parameters provided in the options are either outdated or incorrect according to the latest guidelines:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sperm count &gt; 20 million:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The current guideline indicates that the sperm count should be more than 16 million per milliliter, not 20 million.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Morphology &lt; 8%:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal morphology (shape and structure) of sperm should be more than 4%, not less than 8%. This means that at least 4% of the sperm should have a normal shape.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sperm concentration &lt; 40 million/ml:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct parameter is that sperm concentration should be more than 16 million per milliliter, making this option incorrect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct parameter for normal semen analysis regarding motility is that progressive motility should be more than 32%.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123823.png\" style=\"height:442px; width:1000px\" /></span></span></span></span></p>",
      "correct_choice_id": 191023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5857,
      "choices": [
        {
          "id": 23398,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal hysterectomy</span></p>"
        },
        {
          "id": 23399,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cesarean section</span></p>"
        },
        {
          "id": 23400,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Manchester operation</span></p>"
        },
        {
          "id": 23401,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fothergill's surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The given instrument is used in:</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_Bj2rK4w.jpg\" alt=\"\" width=\"300\" height=\"142\"></span></p>",
      "unique_key": "Q7906196",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585318,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The instrument shown is a <strong>Doyen's retractor</strong>, which is specifically used in cesarean sections. It plays a crucial role during the surgical procedure by retracting the bladder to provide proper exposure of the lower uterine segment. This retraction helps in ensuring a clear view and access to the uterus while minimizing the risk of bladder injury. The Doyen's retractor is used once the utero-vesical fold of peritoneum is opened and the bladder is dissected away from the lower uterine segment. It holds the bladder away from the site of the uterine incision, facilitating a safer and more efficient cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Vaginal hysterectomy:</strong> Involves the removal of the uterus through the vaginal canal and typically uses different types of retractors and instruments designed for vaginal access, not the Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Manchester operation:</strong> This is a surgical procedure used to correct uterovaginal prolapse and does not involve the use of Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fothergill's surgery:</strong> This is performed for uterovaginal prolapse and uses different instruments tailored for vaginal repairs, not the Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Doyen's retractor is used during cesarean sections to retract the bladder and prevent bladder injury while providing exposure of the lower uterine segment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 751, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56931,
      "choices": [
        {
          "id": 227113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 227114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fibroids</span></span></span></p>"
        },
        {
          "id": 227115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sarcoidosis</span></span></span></p>"
        },
        {
          "id": 227116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Genital TB</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old woman whose last delivery was 5 years back presents with secondary amenorrhea of 2 years. She does not bleed on giving estrogen and progesterone. A laparoscopy shows the following. What is the diagnosis? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121347.jpg\" style=\"height:242px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3393998",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Genital TB</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with secondary amenorrhea for two years and does not bleed when given estrogen and progesterone, indicating that the problem lies in the endometrium. The destruction of the endometrium can occur due to two main conditions: Asherman&#39;s syndrome and genital tuberculosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asherman&#39;s syndrome involves intrauterine adhesions typically following a vigorous dilation and curettage (D&amp;C). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genital tuberculosis, however, causes chronic endometritis, leading to the destruction of the endometrium and the absence of withdrawal bleeding upon hormone administration. The laparoscopy shows whitish caseating lesions on the surface of the uterus, which are characteristic of genital tuberculosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Endometriosis</span></strong><span style=\"font-size:12.0pt\">: Endometriosis involves the presence of endometrial tissue outside the uterus, commonly causing pelvic pain and infertility. It does not typically result in secondary amenorrhea or the absence of bleeding on hormone administration, and it does not produce the characteristic whitish lesions seen in the laparoscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Fibroids</span></strong><span style=\"font-size:12.0pt\">: Uterine fibroids are benign smooth muscle tumors of the uterus. They can cause menorrhagia, pelvic pressure, and pain but do not lead to secondary amenorrhea or absence of withdrawal bleeding upon hormone administration. Fibroids also do not present with caseating lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sarcoidosis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis is a multisystem granulomatous disease that rarely affects the genital tract. It does not cause endometrial destruction, secondary amenorrhea, or the absence of withdrawal bleeding when given hormones, nor does it produce the characteristic uterine lesions seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genital tuberculosis can cause chronic endometritis and endometrial destruction, leading to secondary amenorrhea and absence of withdrawal bleeding on hormone administration, with characteristic whitish caseating lesions visible on laparoscopy.</span></span></p>",
      "correct_choice_id": 227116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5884,
      "choices": [
        {
          "id": 23506,
          "text": "<p><span style=\"font-size:12pt;\">Right occipito-posterior</span></p>"
        },
        {
          "id": 23507,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Left occipito-anterior</span></p>"
        },
        {
          "id": 23508,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Left occipito-posterior</span></p>"
        },
        {
          "id": 23509,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Right occipito-anterior</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the fetal position in the given image?&nbsp;</span>(INICET MAY 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-may-2020-3.jpg\" alt=\"\" width=\"250\" height=\"347\"></p>",
      "unique_key": "Q3921915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Right occipito-anterior</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>Right occipito-anterior</strong> (ROA) position means the fetal occiput (the back of the head) is directed towards the mother's right side and anterior (towards the front of the pelvis). This position indicates that the fetus is facing towards the mother's right side with its back towards the front of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In fetal positions:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Right occipito-anterior (ROA)</strong>: The occiput is on the right side and anteriorly towards the front of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Left occipito-anterior (LOA)</strong>: The occiput is on the left side and anteriorly towards the front of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Right occipito-posterior (ROP)</strong>: The occiput is on the right side but posteriorly towards the back of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Left occipito-posterior (LOP)</strong>: The occiput is on the left side but posteriorly towards the back of the pelvis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Right occipito-posterior</strong>: This position indicates that the occiput is on the right side but towards the back of the pelvis, not the front.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Left occipito-anterior</strong>: This position indicates that the occiput is on the left side and anteriorly towards the front of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Left occipito-posterior</strong>: This position indicates that the occiput is on the left side but towards the back of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the Right occipito-anterior (ROA) position, the fetal occiput is directed towards the mother's right side and the anterior part of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 89, DC Ditta’s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23509,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5665,
      "choices": [
        {
          "id": 22632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X chromosome</span></span></span></span></p>"
        },
        {
          "id": 22633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Y chromosome</span></span></span></span></p>"
        },
        {
          "id": 22634,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st chromosome</span></span></span></span></p>"
        },
        {
          "id": 22635,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2nd chromosome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fate of the Mullerian duct is determined by the?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q2608786",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585294,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Y chromosome </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fate of the Mullerian duct is determined by the presence or absence of the Y chromosome, specifically the SRY gene located on the short arm of the Y chromosome. The SRY gene produces testis-determining factor (TDF), which induces the development of the bipotential gonads into testes. The Sertoli cells in the testes secrete Anti-Mullerian Hormone (AMH), which causes regression of the Mullerian ducts, structures that would otherwise develop into female internal genitalia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fate of the Mullerian duct is determined by the presence or absence of the Y chromosome, specifically the SRY gene, which leads to the secretion of Anti-Mullerian Hormone (AMH) by the Sertoli cells and regression of the Mullerian ducts in males.</span></span></span></span></p>",
      "correct_choice_id": 22633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6065,
      "choices": [
        {
          "id": 24230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spiral artery by villous trophoblasts</span></span></span></p>"
        },
        {
          "id": 24231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radial artery by cytotrophoblasts</span></span></span></p>"
        },
        {
          "id": 24232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spiral artery by extravillous trophoblasts</span></span></span></p>"
        },
        {
          "id": 24233,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arcuate artery by extravillous trophoblasts</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman with no other comorbid conditions develops preeclampsia. She enquires about the cause of her condition. The doctor explains that it is due to the failure of the invasion of? </span></span>(NEET PG 2022)</p>",
      "unique_key": "Q5888603",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585301,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Spiral artery by extravillous trophoblasts </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preeclampsia occurs due to the failure of the invasion of extravillous trophoblasts into the spiral artery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spiral artery supplies blood to the endometrium. In normal pregnancy, there is an invasion of the extravillous trophoblasts (specifically, endovascular trophoblasts) into the walls of the spiral arteries.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process takes place in two waves:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First wave (10-12 weeks):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endovascular trophoblasts invade up to the decidual segments.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Second wave (16-18 weeks):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endovascular trophoblasts invade up to the myometrial segments.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This invasion results in the distension of the spiral arterioles, transforming them into a low-resistance, low-pressure, and high-flow system.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In preeclampsia, the failure of the second wave of endovascular trophoblastic invasion into uterine vessels leads to decreased placental perfusion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Spiral artery by villous trophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villous trophoblasts are involved in the formation of the placental villi, but they do not invade the spiral arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Radial artery by cytotrophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The radial arteries supply the deeper layers of the myometrium and are not primarily involved in the pathogenesis of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Arcuate artery by extravillous trophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The arcuate arteries are part of the uterine arterial system, but their invasion by trophoblasts is not relevant to the development of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preeclampsia is caused by the failure of extravillous trophoblasts to invade the spiral arteries, leading to decreased placental perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1818, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5667,
      "choices": [
        {
          "id": 22640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asking the patient to void and see if the pessary is in place</span></span></span></span></p>"
        },
        {
          "id": 22641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seeing if the patient feels any discomfort, which means that the pessary is retained</span></span></span></span></p>"
        },
        {
          "id": 22642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asking the patient to perform the Valsalva manuever and see if the pessary is in place</span></span></span></span></p>"
        },
        {
          "id": 22643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Being able to admit two fingers between the ring and the pessary</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the first step after fitting the pessary to check if the pessary is adequately retained?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q4908590",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585295,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Asking the patient to perform the Valsalva maneuver and see if the pessary is in place </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/7.jpg\" style=\"height:382px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A vaginal pessary is a device used to support the pelvic organs in women with uterovaginal prolapse who are either unfit for surgery or unwilling to undergo surgery. The fitting process involves several steps to ensure the pessary is comfortable and effective:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient Preparation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The patient is positioned in the lithotomy position and should have an empty bladder and rectum.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal Examination</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An assessment of vaginal length and width is performed to estimate the appropriate pessary size.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insertion</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The pessary is lubricated and inserted in a cephalad direction against the posterior vaginal wall.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placement Check</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An index finger is directed into the posterior vaginal fornix to ensure the cervix is above the pessary, and the pessary should fit snugly against the vaginal walls without causing pain.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adequacy Check</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The patient is asked to perform a Valsalva maneuver (forceful exhalation against a closed airway) to see if the pessary remains in place, ensuring it is not dislodged during increased intra-abdominal pressure.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functionality Check</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The patient should be able to stand, walk, cough, and urinate without difficulty or discomfort.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Asking the patient to void and see if the pessary is in place</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While checking the ability to void is important, it is not the first step after fitting the pessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Seeing if the patient feels any discomfort, which means that the pessary is retained</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Patient comfort is crucial, but discomfort does not necessarily mean the pessary is adequately retained.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Being able to admit two fingers between the ring and the pessary</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not a standard method for checking the fit of a pessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After fitting a pessary, the first step to check if it is adequately retained is to ask the patient to perform the Valsalva maneuver and see if the pessary remains in place.</span></span></span></span></p>",
      "correct_choice_id": 22642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6079,
      "choices": [
        {
          "id": 24285,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cry of baby in the womb</span></span></span></p>"
        },
        {
          "id": 24286,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of vagina</span></span></span></p>"
        },
        {
          "id": 24287,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of uterus</span></span></span></p>"
        },
        {
          "id": 24288,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of both vagina and uterus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is vagitus uterinus?&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q1796532",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585310,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cry of baby in the womb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term used to describe the cry of a baby in the womb. It is a rare phenomenon but can occur if there is a rupture of the amniotic sac with air entry, allowing the baby to make crying sounds while still in utero.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus vaginus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term for the cry of the baby in the vagina, which can be heard during delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> causes vaginitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may affect its layers, leading to conditions such as endometritis (infection of the endometrium), myometritis (infection of the myometrium), and perimetritis (infection of the perimetrium).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Infection of vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the vagina causes vaginitis, which is not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Infection of uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the uterus can lead to endometritis, myometritis, or perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Infection of both vagina and uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of both the vagina and uterus involves conditions such as vaginitis and endometritis/myometritis/perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus refers to the cry of a baby in the womb, which is a rare phenomenon that can occur if there is a rupture of the amniotic sac with air entry.</span></span></span></p>",
      "correct_choice_id": 24285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5984,
      "choices": [
        {
          "id": 23906,
          "text": "<p><span style=\"font-size:12pt;\">Anencephaly</span></p>"
        },
        {
          "id": 23907,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Omphalocele</span></p>"
        },
        {
          "id": 23908,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cystic hygroma</span></p>"
        },
        {
          "id": 23909,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Encephalocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A doctor tells a 31-year-old woman, who is 20 weeks pregnant, that her baby has a developmental defect. She has come to you for a second opinion. The following US finding is seen. Identify the defect?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/picture9.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q9594980",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585317,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anencephaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given ultrasound image shows an open neural tube defect in the calvaria (skull), which is consistent with the diagnosis of anencephaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Anencephaly:</strong> Results from incomplete closure of the neural tube. It can be detected as early as 10 to 11 weeks of gestation.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Ultrasound Signs:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\"><strong>Frog eye sign:</strong> Absence of cranial calvaria with prominent orbits, resembling the face of a frog.</span></li><li><span style=\"font-size:12pt;\"><strong>Shower cap sign:</strong> Absence of the cranium leading to the protrusion of a disorganized mass of brain tissue, resembling a shower cap and giving rise to a characteristic triangular facial appearance.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prevention:</strong> Can be prevented by pre-conceptional folic acid supplementation (5 mg) for at least 3 months.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Omphalocele:&nbsp;</strong>Congenital herniation of abdominal contents through a defect in the abdominal wall covered by a membrane. It is different from gastroschisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cystic hygroma:&nbsp;</strong>Lymphangioma occurring in the head-neck region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Encephalocele:</strong> Protrusion of the brain and membranes through a cranial defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anencephaly is an open neural tube defect characterized by the absence of the cranial calvaria and prominent orbits, detectable by ultrasound as early as 10 to 11 weeks of gestation. It can be prevented with pre-conceptional folic acid supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg 201, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg471</strong></span></p>",
      "correct_choice_id": 23906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47855,
      "choices": [
        {
          "id": 191015,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8-10 weeks</span></span></span></span></p>"
        },
        {
          "id": 191016,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">11-14 weeks</span></span></span></span></p>"
        },
        {
          "id": 191017,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">16-18 weeks</span></span></span></span></p>"
        },
        {
          "id": 191018,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">18-20 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At what period of gestation is the nuchal translucency measured? </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(FMGE JANUARY 2024)</span></span></span></span></p>",
      "unique_key": "Q4871592",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585326,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 11-14 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nuchal translucency (NT) measurement is an ultrasound marker used for the screening of chromosomal abnormalities, particularly Down syndrome (trisomy 21). The optimal time to measure NT is between 11 and 14 weeks of gestation, more specifically between 11 weeks and 13 weeks and 6 days. During this period, the NT measurement is most accurate and predictive. The NT scan involves measuring the clear space in the tissue at the back of the baby&#39;s neck. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An absent Nasal Bone (NB) and increased NT measurement both are the marker of Trisomy 21 (Down syndrome).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123543.png\" style=\"height:217px; width:300px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nuchal translucency should be measured between 11 and 14 weeks of gestation to effectively screen for chromosomal abnormalities like Down syndrome.</span></span></span></span></p>",
      "correct_choice_id": 191016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5875,
      "choices": [
        {
          "id": 23470,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hot flashes</span></span></span></p>"
        },
        {
          "id": 23471,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAD Prophylaxis</span></span></span></p>"
        },
        {
          "id": 23472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteoporosis</span></span></span></p>"
        },
        {
          "id": 23473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature menopause</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy is not indicated for:&nbsp;</span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q3545924",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585329,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) CAD Prophylaxis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) is not recommended for the prophylaxis of coronary artery disease (CAD). Although there was some belief in the past that HRT might provide cardiovascular benefits, extensive research has shown that HRT does not prevent CAD and may, in fact, increase the risk of certain cardiovascular events in some women.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HRT is primarily indicated for the management of symptoms associated with menopause and for certain therapeutic and prophylactic uses:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Indications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadal dysgenesis in adolescents</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ovarian failure</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hot flashes (vasomotor symptoms)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal dryness</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylactic Indications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevention of osteoporosis in postmenopausal women</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risks of HRT:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of endometrial cancer (particularly with unopposed estrogen in women with an intact uterus)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of breast cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of ovarian cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of thromboembolism</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Possible adverse effects on lipid profiles</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased risk of gallstones and liver dysfunction</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hot flashes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HRT is widely used to manage hot flashes and other vasomotor symptoms associated with menopause. It is one of the most effective treatments for these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Osteoporosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HRT is used prophylactically to prevent osteoporosis in postmenopausal women by maintaining bone density and reducing the risk of fractures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Premature menopause:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Women experiencing premature menopause or premature ovarian failure can benefit from HRT to manage symptoms and reduce the long-term risks associated with early loss of estrogen, including osteoporosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) is not indicated for the prophylaxis of coronary artery disease (CAD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg 61,62</span></strong></span></span></p>",
      "correct_choice_id": 23471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21816,
      "choices": [
        {
          "id": 87228,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichomoniasis</span></span></span></p>"
        },
        {
          "id": 87229,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacterial Vaginosis</span></span></span></p>"
        },
        {
          "id": 87230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydial Cervicitis</span></span></span></p>"
        },
        {
          "id": 87231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candidiasis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman presented to OPD with complaint of greenish-frothy vaginal discharge for 1 month. Examination revealed finding as shown in image. On saline microscopy, motile organisms are noticed. What is the likely diagnosis?</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;(FMGE jan 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1050.jpg\" style=\"height:254px; width:300px\" /></span></span></p>",
      "unique_key": "Q1573735",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585304,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Trichomoniasis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical scenario and image showing strawberry cervix, is suggestive of Trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-115204.png\" style=\"height:651px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bacterial Vaginosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discharge: White, thin, homogenous with a foul odor.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis: Amsel Criteria - clue cells on wet mount, whiff test positive, pH &gt; 4.5, homogenous discharge.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms: Usually no erythema or significant irritation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chlamydial Cervicitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically associated with mucopurulent cervical discharge and may not present with frothy discharge or a strawberry cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis: Nucleic acid amplification tests (NAAT) are used to detect Chlamydia trachomatis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Candidiasis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discharge: Thick, curdy white with no odor.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis: KOH prep revealing pseudohyphae or spores, wet mount.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms: Pruritis and dysuria with notable erythema.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichomoniasis is characterized by greenish-frothy vaginal discharge, a strawberry cervix, and motile organisms on saline microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s Textbook of Gynaecology 6<sup>th</sup> edition page 166</span></strong></span></span></p>",
      "correct_choice_id": 87228,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5855,
      "choices": [
        {
          "id": 23390,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CMV</span></span></span></p>"
        },
        {
          "id": 23391,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus</span></span></span></p>"
        },
        {
          "id": 23392,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxoplasma</span></span></span></p>"
        },
        {
          "id": 23393,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is the cause of Hydrops fetalis?&nbsp;</span></span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q7900777",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585316,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Parvovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis. (Non immune hydrops)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 infects fetal erythroid progenitor cells and causes anemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe anemia leads to high-output cardiac failure and hydrops fetalis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. CMV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Typically causes peri-ventricular calcifications in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Toxoplasmosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Causes:&nbsp; hydrocephalus, chorioretinitis, cerebral calcification, microcephaly, seizures and mental retardation in the newborn.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. HIV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vertical transmission of HIV from mother to infant can occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis due to its effect on fetal erythroid progenitor cells, leading to severe anemia and subsequent high-output cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 347, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23225,
      "choices": [
        {
          "id": 92864,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases risk of Colon cancer</span></span></span></p>"
        },
        {
          "id": 92865,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of breast cancer</span></span></span></p>"
        },
        {
          "id": 92866,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of endometrial cancer</span></span></span></p>"
        },
        {
          "id": 92867,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases risk of osteoporosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true association related to HRT (Hormone replacement therapy) among the options provided?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q6606855",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585305,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Decreases risk of Colon cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) has been associated with a decreased risk of colon cancer. Studies have shown that estrogen in HRT may have a protective effect against the development of colon cancer. This effect is believed to be related to estrogen&rsquo;s impact on gastrointestinal mucosal growth and repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased risk of breast cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT, particularly with estrogen and progestin, is associated with an increased risk of breast cancer. Long-term use of combined HRT has been shown to elevate the risk of breast cancer in several studies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased risk of endometrial cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. Unopposed estrogen (estrogen alone without progestin) increases the risk of endometrial cancer. To mitigate this risk, progestin is often added to HRT in women with an intact uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increases risk of osteoporosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT is actually used prophylactically to reduce the risk of osteoporosis. Estrogen helps maintain bone density and prevent bone loss, which is beneficial in managing osteoporosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) decreases the risk of colon cancer.</span></span></span></p>",
      "correct_choice_id": 92864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5885,
      "choices": [
        {
          "id": 23510,
          "text": "<p><span style=\"font-size:12pt;\">Gently replace the cord inside the vagina</span></p>"
        },
        {
          "id": 23511,
          "text": "<p><span style=\"font-size:12pt;\">Inform the doctor and shift to OT</span></p>"
        },
        {
          "id": 23512,
          "text": "<p><span style=\"font-size:12pt;\">Put her in Trendelenburg position</span></p>"
        },
        {
          "id": 23513,
          "text": "<p><span style=\"font-size:12pt;\">Do vaginal examination and find the fetal presentation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A midwife is examining a pregnant woman in labour when she noticed that there is cord prolapse. What should be the next immediate step of management?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q6940306",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585336,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Put her in Trendelenburg position</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cord prolapse is an obstetric emergency where the umbilical cord slips ahead of the presenting part of the fetus in the birth canal, leading to compression of the cord. This compression can restrict blood flow and oxygen to the fetus, causing fetal distress or hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The immediate management of cord prolapse includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Relieving pressure off the cord</strong>: This is crucial to prevent fetal hypoxia. This can be achieved by positioning the patient in a way that minimizes pressure on the cord.</span></li><li><span style=\"font-size:12pt;\"><strong>Trendelenburg position</strong>: This position involves tilting the patient’s body with the head down and the pelvis up. This helps to shift the fetal presenting part off the prolapsed cord and relieves compression.</span></li><li><span style=\"font-size:12pt;\"><strong>Left lateral position or All-fours position</strong>: Alternative positions can also help in relieving pressure on the cord.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While preparing for an emergency cesarean section (LSCS) to deliver the fetus urgently, these positions and techniques are used to temporarily alleviate the pressure on the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Gently replace the cord inside the vagina</strong>: Attempting to reposition the cord is not recommended as it can cause further damage or spasm of the vessels in the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Inform the doctor and shift to OT</strong>: While informing the doctor and preparing for cesarean delivery is necessary, immediate steps to relieve cord compression should be taken first.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Do vaginal examination and find the fetal presentation</strong>: This may be done, but the primary focus should be on relieving the pressure on the cord immediately to prevent fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the case of cord prolapse, placing the patient in Trendelenburg position helps to relieve pressure on the prolapsed cord and is a critical step in managing the emergency until a cesarean section can be performed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1129, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44009,
      "choices": [
        {
          "id": 175695,
          "text": "<p><span style=\"font-size:12pt;\">E1 + E2</span></p>"
        },
        {
          "id": 175696,
          "text": "<p><span style=\"font-size:12pt;\">E6 + E7</span></p>"
        },
        {
          "id": 175697,
          "text": "<p><span style=\"font-size:12pt;\">L1</span></p>"
        },
        {
          "id": 175698,
          "text": "<p><span style=\"font-size:12pt;\">L2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the antigen present in the recombinant HPV vaccine?&nbsp; </span>(INICET NOV 2023)</p>",
      "unique_key": "Q4742046",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) L1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The recombinant HPV vaccine primarily includes the L1 protein, which self-assembles into virus-like particles, providing the basis for immune recognition without causing the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. E1 + E2:</strong> E1 and E2 are early viral proteins, not included in vaccines due to their role in viral replication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. E6 + E7:&nbsp;</strong>E6 and E7 are proteins involved in oncogenesis, not appropriate for vaccine development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. L2:</strong> L2 is also a capsid protein but not the primary antigen used in current HPV vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The L1 protein of HPV forms the basis of the recombinant HPV vaccine, effectively stimulating an immune response by mimicking the virus structure.</span></p>",
      "correct_choice_id": 175697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5686,
      "choices": [
        {
          "id": 22716,
          "text": "<p><span style=\"font-size:12pt;\">G4P2 L1 A2</span></p>"
        },
        {
          "id": 22717,
          "text": "<p><span style=\"font-size:12pt;\">G4P1 A2 L1</span></p>"
        },
        {
          "id": 22718,
          "text": "<p><span style=\"font-size:12pt;\">G5PO L1 A2</span></p>"
        },
        {
          "id": 22719,
          "text": "<p><span style=\"font-size:12pt;\">G5P1 A2 L1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman came to OPD with a twin pregnancy at 10 weeks of gestation. She has a 3-year-old female child who was born at term and had 2 first trimester abortions previously. Which of the following is the correct representation of her obstetric score/formula?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q8582428",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585302,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) G4P1 A2 L1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Determining the Parity Index/ Obstetric Formula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2 formulas</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. G __ P __ L __ A ___</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</span></li><li><span style=\"font-size:12pt;\">Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</span></li><li><span style=\"font-size:12pt;\">Living (L): The total number of living children the woman has.</span></li><li><span style=\"font-size:12pt;\">Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The obstetric score here is G4P1A2L1.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is another way to write the formula.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>IMPORTANT</u>: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2.</strong></span></p>",
      "correct_choice_id": 22717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5908,
      "choices": [
        {
          "id": 23602,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV</span></span></span></p>"
        },
        {
          "id": 23603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿III</span></span></span></p>"
        },
        {
          "id": 23604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿II</span></span></span></p>"
        },
        {
          "id": 23605,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿I</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows what grade of placenta previa?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;(NEET PG 2019)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/neet-pg-obg-2019-1.jpg\" style=\"height:365px; width:250px\" /></p>",
      "unique_key": "Q1212959",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585288,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) III </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image illustrates Type 3 placenta previa where the placenta partially covers the internal os. This classification is part of the older classification system known as Browne&rsquo;s classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta previa is categorized into different types based on how much the placenta covers the internal os of the cervix:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Older Classification (Browne&rsquo;s classification):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The lower edge of the placenta enters the lower segment but is away from the os.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The placenta reaches the margin of the os but doesn&rsquo;t cover it.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 3:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The placenta partially covers the internal os (when fully dilated, it doesn&rsquo;t cover).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 4:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The placenta completely covers the os.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Newer Classification (based on Transvaginal Sonography - TVS; by ACOG):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True Placenta Previa:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The placenta covers the internal os.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low-lying Placenta:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The placenta lies within 2 cm of the internal os but does not cover it.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IV:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This would mean the placenta completely covers the os, which is not the case in the given image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This would mean the placenta reaches the margin of the os but does not cover it, which is not consistent with the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. I:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This would mean the lower edge of the placenta enters the lower segment but is away from the os, which does not align with the given image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta previa is classified based on the extent to which the placenta covers the internal os, with Type 3 indicating partial coverage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Types of Placentae previa</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Older Classification (Browne&rsquo;s classification)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-72.jpg\" style=\"height:125px; width:900px\" /></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-73.jpg\" style=\"height:260px; width:600px\" /></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Newer Classification&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(based on Transvaginal Sonography -TVS); By ACOG</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True Placenta Previa: Placenta covers the internal os</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low lying placenta: Placenta lies within 2 cm of the internal os but does not cover it.&nbsp;</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 658, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21819,
      "choices": [
        {
          "id": 87240,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lochia Serosa </span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Alba </span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Rubra</span></span></span></p>"
        },
        {
          "id": 87241,
          "text": "<p><span style=\"font-size:12pt\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:Calibri,sans-serif\">Lochia Serosa </span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:Calibri,sans-serif\"> Lochia Rubra </span><span dir=\"ltr\" lang=\"PT-BR\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:Calibri,sans-serif\">&nbsp;Lochia Alba</span></span></p>"
        },
        {
          "id": 87242,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lochia Rubra&nbsp;</span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Serosa&nbsp;</span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Alba</span></span></span></p>"
        },
        {
          "id": 87243,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lochia Rubra </span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Alba&nbsp;</span><span style=\"font-family:Wingdings\">&rarr;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Serosa</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mark the correct sequence of vaginal discharge during puerperium:</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(FMGE Jan 2023)</p>",
      "unique_key": "Q8526671",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585309,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lochia Rubra </span></strong><strong><span style=\"font-family:Wingdings\">&rarr;</span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Serosa </span></strong><strong><span style=\"font-family:Wingdings\">&rarr;</span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lochia Alba</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lochia is vaginal discharge after delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is composed of sloughed off decidua, blood, necrotic debris and secretions of the cervixand vagina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1052.jpg\" style=\"height:350px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct sequence of lochia during the puerperium is Lochia Rubra (red, first 3-4 days), Lochia Serosa (yellowish-brownish, 5-9 days), and Lochia Alba (white, lasts 10-28 days).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> Edition page 170&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>",
      "correct_choice_id": 87242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5932,
      "choices": [
        {
          "id": 23698,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum FSH levels</span></p>"
        },
        {
          "id": 23699,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum testosterone levels</span></p>"
        },
        {
          "id": 23700,
          "text": "<p><span style=\"font-size:12.0pt;\">Testicular Biopsy</span></p>"
        },
        {
          "id": 23701,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum LH level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple presents to the infertility clinic with a normal hysterosalpingogram and a semen analysis report with azoospermia. Which of the following test is useful to differentiate between an obstructive and a testicular cause?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q9527620",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585299,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Testicular Biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The absence of sperm in semen is known as azoospermia. It can be due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Pre-testicular azoospermia due to a hypothalamic or pituitary abnormality (hypogonadotropic hypogonadism)</span></li><li><span style=\"font-size:12.0pt;\">Testicular failure or non-obstructive azoospermia</span></li><li><span style=\"font-size:12.0pt;\">Post-testicular obstruction implies normal spermatogenesis but failure to deliver the sperm into the ejaculate because of ducal obstruction.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">In testicular cause of azoospermia, there will be absent or very few sperms on biopsy whereas in obstructive azoospermia, there will be normal sperms on biopsy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum FSH levels&nbsp;</strong>and <strong>Option B. Serum testosterone levels</strong> are important for spermatogenesis</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">FSH levels can be used to differentiate hypogonadotrophic hypogonadism from other causes of testicular failure</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum LH level</strong>: LH is a non-specific test in evaluation of azoospermia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A testicular biopsy is useful to differentiate between an obstructive and a testicular cause of Azoospermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 233, DC Dutta’s Textbook of Gynecology 6the edition</strong></span></p>",
      "correct_choice_id": 23700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21778,
      "choices": [
        {
          "id": 87076,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian tumour</span></p>"
        },
        {
          "id": 87077,
          "text": "<p><span style=\"font-size:12pt;\">Polycystic ovarian syndrome</span></p>"
        },
        {
          "id": 87078,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian hyperstimulation syndrome</span></p>"
        },
        {
          "id": 87079,
          "text": "<p><span style=\"font-size:12pt;\">Endometriosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following conditions, ovarian drilling is beneficial?</span>&nbsp;(FMGE JANUARY 2024)</p>",
      "unique_key": "Q5109767",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585293,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Polycystic ovarian syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopic ovarian drilling is used in management of polycystic ovarian syndrome</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of PCOS typically starts lifestyle modification.&nbsp; Medical management with metformin (for insulin resistance) and then depending on the symptoms that a patient presents with such as irregular menses (OC pills, Progesterone), hirsuitism (cyproterone acetate, Spironolactone) or infertility (Oral Ovulogens such as letrozole, clomiphene) may be considered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ovarian drilling is NOT a first-line treatment and may be considered in resistant cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>LAPAROSCOPIC OVARIAN DRILLING</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Small holes are made in follicles to resume ovulation in women who are not responding to drugs.</span></li><li><span style=\"font-size:12pt;\">Advantage: induce the resumption of ovulation in more than 50% females</span></li><li><span style=\"font-size:12pt;\">Disadvantages: invasive procedure, can cause adhesion.</span></li><li><span style=\"font-size:12pt;\">4 drills should be done in each ovary. Depth of 4mm for 4 seconds.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1032.jpg\" alt=\"\" width=\"400\" height=\"279\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Ovarian tumour</strong>: Treatment would generally involve laparotomy or laparoscopy&nbsp; for surgical excision depending on various factors such as whether benign or malignant, size of tumour , staging etc</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ovarian hyperstimulation syndrome</strong>:&nbsp; It occurs as a complication of ovarian stimulation used in ART procedures characterized by enlarged ovaries and third space fluid loss due to increased capillary permeability progressing to ascites, pleural effusion. It is managed conservatively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Endometriosis</strong>: It is characterized by the presence of ectopic endometrium in locations other than the endometrial lining. Treatment may be conservative medical management or surgical excision of the endometriotic lesions</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopic ovarian drilling is used in management of polycystic ovarian syndrome</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of Gynaecology page471</strong></span></p>",
      "correct_choice_id": 87077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54776,
      "choices": [
        {
          "id": 218569,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCMA (Monochorionic Monoamniotic)</span></span></p>"
        },
        {
          "id": 218570,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCDA (Monochorionic Diamniotic)</span></span></p>"
        },
        {
          "id": 218571,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MADC (Monoamniotic Dichorionic)</span></span></p>"
        },
        {
          "id": 218572,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DADC (Dichorionic Diamniotic)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which will you not see in twin pregnancy? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q5352974",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585332,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) MADC (Monoamniotic Dichorionic)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct answer is <strong>MADC (Monoamniotic Dichorionic)</strong>. The classification of twin pregnancies is based on the timing of the zygote&#39;s division and the resulting structures, such as the number of chorions (placentas) and amnions (amniotic sacs) that form.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dichorionic Diamniotic (DCDA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins occur when the division happens very early (within the first 72 hours after fertilization), resulting in two separate chorions and amnions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monochorionic Diamniotic (MCDA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins occur when the division happens between the 4th and 8th day after fertilization, after the chorion has formed but before the amniotic sac has split.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monochorionic Monoamniotic (MCMA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins result from division that occurs between the 9th and 12th day after fertilization, after both the chorion and amnion have formed, leading to two embryos sharing a single amniotic sac and a single chorion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoamniotic Dichorionic (MADC)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not a possible scenario. The formation of a single amnion with two separate chorions (placentas) does not occur because the chorion forms before the amnion. Thus, this combination is anatomically and developmentally impossible.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. MCMA (Monochorionic Monoamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a recognized type of twin pregnancy where twins share both the chorion and the amnion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. MCDA (Monochorionic Diamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Another recognized type, where twins share a chorion but have separate amniotic sacs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DADC (Dichorionic Diamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the most common type of twin pregnancy, especially in dizygotic (fraternal) twins, where each twin has its own chorion and amnion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoamniotic Dichorionic (MADC) is not a possible configuration in twin pregnancies. The formation of the amnion and chorion follows a specific sequence that does not allow for this combination. Understanding the timing and resulting structures of zygote division is crucial in determining the type of twin pregnancy.</span></span></span></p>",
      "correct_choice_id": 218571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5983,
      "choices": [
        {
          "id": 23902,
          "text": "<p><span style=\"font-size:12pt;\">Formalin</span></p>"
        },
        {
          "id": 23903,
          "text": "<p><span style=\"font-size:12pt;\">Air dried</span></p>"
        },
        {
          "id": 23904,
          "text": "<p><span style=\"font-size:12pt;\">Normal saline</span></p>"
        },
        {
          "id": 23905,
          "text": "<p><span style=\"font-size:12pt;\">95% ethanol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the fixative used for a pap smear?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q6641651",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585321,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 95% ethanol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common fixative used in a Pap smear is 95% ethyl alcohol (ethanol). This fixative helps preserve the cells collected on the slides for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Formalin:</strong> Formalin (10%) is commonly used as a fixative for histology specimens but is not used for Pap smears.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Air dried:</strong> Air drying is not a method used for preserving Pap smear specimens as it can lead to poor preservation of cellular details.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal saline:</strong> Normal saline is not a fixative. Tissues must be immediately transferred to formol saline if using normal saline temporarily.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The fixative used for a Pap smear is typically 95% ethanol, which helps preserve the cellular details on the slides for accurate cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23905,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6009,
      "choices": [
        {
          "id": 24006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandins play an important role. Thromboxane A2 decreases; Prostacyclin: Thromboxane ratio increases in preeclampsia</span></span></span></p>"
        },
        {
          "id": 24007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell dysfunction leads to reduced nitric oxide levels and this causes the clinical presentation of preeclampsia</span></span></span></p>"
        },
        {
          "id": 24008,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasoconstriction leads to ischemia, necrosis and hemorrhage and end organ damage seen in preeclampsia</span></span></span></p>"
        },
        {
          "id": 24009,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-angiogenic factors play an important role in preeclampsia. There is an increase in FIt-1 and decrease in PIGF</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are theories of causation of preeclampsia except:&nbsp;</span></span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q6263408",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585333,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prostaglandins play an important role. Thromboxane A2 decreases; Prostacyclin: Thromboxane ratio increases in preeclampsia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are theories of causation of preeclampsia except option A. There is reduced or absent prostacyclin (PGI,) production with increased production of thromboxane (TXA,) and reduced ratio of prostacyclin: thromboxane in preeclampsia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endothelial cell dysfunction leads to reduced nitric oxide levels and this causes the clinical presentation of preeclampsia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell dysfunction is another etiology. Injured or activated endothelial cells may produce less nitric oxide and may secrete substances that promote coagulation and vasopressor sensitivity. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vasoconstriction leads to ischemia, necrosis and hemorrhage and end organ damage seen in preeclampsia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasospasm has long been associated with preeclampsia. Systemic endothelial activation causes vasospasm, which elevates resistance to produce hypertension. With diminished blood flow because of maldistribution from vasospasm and interstitial leakage, ischemia of the surrounding tissues can cause necrosis, hemorrhage, and other end-organ disturbances. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Anti-angiogenic factors play an important role in preeclampsia. There is an increase in FIt-1 and decrease in PIGF:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiogenic Factors: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental vasculogenesis is evident 21 days after conception. Two antiangiogenic peptides that are increased</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Soluble fms-like tyrosine kinase 1 (s-flt-1)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Soluble endoglin (s-eng)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factors that are decreased are</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PlGF</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAPP-A</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VEGF</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-237.jpg\" style=\"height:407px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In preeclampsia, the prostacyclin: thromboxane ratio is decreased due to increased thromboxane A2 and decreased prostacyclin (PGI2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1802, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5968,
      "choices": [
        {
          "id": 23842,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome</span></span></span></p>"
        },
        {
          "id": 23843,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism</span></span></span></p>"
        },
        {
          "id": 23844,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ovarian failure</span></span></span></p>"
        },
        {
          "id": 23845,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delayed blood transfusion reaction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old female patient came with a history of fatiguability and constipation for the past 1 year. She has a history of multiple blood transfusions after delivery 4 years ago. She has had lactational failure and never regained her periods after the delivery. What is the most probable diagnosis?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2021)</p>",
      "unique_key": "Q3936607",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585315,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sheehan syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most probable diagnosis in a woman with lactational failure and postpartum amenorrhea, now presenting with fatiguability and constipation, is Sheehan syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome refers to panhypopituitarism occurring as a result of pituitary ischemia and necrosis following massive obstetrical hemorrhage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The history of multiple blood transfusions after delivery indicates significant blood loss, which resulted in pituitary ischemia leading to this condition.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms such as fatiguability and constipation can be attributed to secondary hypothyroidism resulting from pituitary dysfunction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypothyroidism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>While hypothyroidism can cause fatiguability and constipation, the history of postpartum amenorrhea and lactational failure makes Sheehan syndrome more likely. In Sheehan syndrome, hypothyroidism is a secondary consequence of pituitary dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Premature ovarian failure</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Premature ovarian failure typically presents with symptoms of estrogen deficiency such as hot flashes and vaginal dryness, along with amenorrhea. However, it does not account for the history of significant postpartum hemorrhage and lactational failure seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Delayed blood transfusion reaction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Delayed blood transfusion reactions usually present with symptoms such as jaundice, fever, and anemia, but they do not explain the chronic symptoms of fatiguability, constipation, lactational failure, and amenorrhea in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome is characterized by panhypopituitarism due to pituitary ischemia and necrosis following massive obstetrical hemorrhage, leading to symptoms such as lactational failure, amenorrhea, fatiguability, and constipation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 465, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23842,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5832,
      "choices": [
        {
          "id": 23298,
          "text": "<p><span style=\"font-size:12pt;\">Biophysical profile</span></p>"
        },
        {
          "id": 23299,
          "text": "<p><span style=\"font-size:12pt;\">Fetal blood sampling</span></p>"
        },
        {
          "id": 23300,
          "text": "<p><span style=\"font-size:12pt;\">Amniospectometry</span></p>"
        },
        {
          "id": 23301,
          "text": "<p><span style=\"font-size:12pt;\">MCA doppler peak systolic velocity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In modern obstetrics, which of the following investigations is used for monitoring the fetus of an Rh- negative sensitized mother? (NEET PG 2020)</span></p>",
      "unique_key": "Q5251471",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585312,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) MCA doppler peak systolic velocity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A Doppler of the middle cerebral artery indirectly gives evidence of fetal anemia</span></li><li><span style=\"font-size:12pt;\">An anemic fetus (For e.g. due to fetal red cell destruction in an Rh iso-immunized mother) will re-direct blood flow to more important organs like the brain.</span></li><li><span style=\"font-size:12pt;\">This is reflected by an increased flow in the middle cerebral artery which can be measured by doing a Doppler of the MCA</span></li><li><span style=\"font-size:12pt;\">In Rh immunized mothers, when indirect Coomb’s Test (ICT) titers rise above the critical titer of 1:16, then MCA doppler peak systolic velocity (PSV) is used for monitoring fetal anemia and development of hydrops in these babies.</span></li><li><span style=\"font-size:12pt;\">MCA-PSV has replaced amniocentesis as it is a non-invasive test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Biophysical Profile</strong>: Biophysical Profile is a test of antepartum fetal assessment</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Fetal blood sampling or Cordocentesis</strong>: This is done only when the fetal MCA doppler shows a peak systolic velocity of &gt; 1.5 MoMs</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amnio-spectrometry</strong>: This is no longer done as it is an invasive method of measuring the amount of bilirubin in the amniotic fluid to determine the level of fetal anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MCA Doppler peak systolic velocity is used to monitor fetal anemia in Rh-negative sensitized mothers due to its non-invasive nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 931, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47889,
      "choices": [
        {
          "id": 191151,
          "text": "<p><span style=\"font-size:12.0pt;\">Previous h/o preeclampsia</span></p>"
        },
        {
          "id": 191152,
          "text": "<p><span style=\"font-size:12.0pt;\">Previous preterm delivery</span></p>"
        },
        {
          "id": 191153,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        },
        {
          "id": 191154,
          "text": "<p><span style=\"font-size:12.0pt;\">Poorly controlled diabetes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A high dose of folic acid should be given pre-conceptionally in women with? (FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q9630752",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585284,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Poorly controlled diabetes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A high dose of folic acid is recommended pre-conceptionally for women who are at a higher risk of neural tube defects. This includes women with poorly controlled diabetes, which is associated with an increased risk of congenital abnormalities, including neural tube defects. A high dose of folic acid (4 to 5 mg daily) should be started at least three months before conception to reduce this risk and to be given till 16 weeks of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Previous h/o preeclampsia:&nbsp;</strong>The preventive strategy for women with a history of preeclampsia includes the use of low-dose aspirin (Ecosprin), not high-dose folic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Previous preterm delivery:&nbsp;</strong>Management includes progesterone supplementation or considering a cervical cerclage in cases of cervical insufficiency, rather than high-dose folic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sickle cell anemia:&nbsp;</strong>While folic acid is important in hemoglobinopathies, the primary concern in sickle cell anemia is maintaining adequate folic acid levels due to increased hemolysis, but it is not specifically indicated at high doses for pre-conception.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Women with poorly controlled diabetes, epileptics, should receive a high dose of folic acid pre-conceptionally to reduce the risk of neural tube defects.</span></p>",
      "correct_choice_id": 191154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6080,
      "choices": [
        {
          "id": 24289,
          "text": "<p><span style=\"font-size:12pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 24290,
          "text": "<p><span style=\"font-size:12pt;\">Clear cell adenocarcinoma</span></p>"
        },
        {
          "id": 24291,
          "text": "<p><span style=\"font-size:12pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 24292,
          "text": "<p><span style=\"font-size:12pt;\">Sarcoma botryoides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The daughter of a woman who received diethylstilbestrol during her pregnancy is at higher risk for?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9258403",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585311,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Clear cell adenocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diethylstilbestrol (DES)</strong> is a synthetic estrogen that was previously prescribed to pregnant women to prevent miscarriages and other pregnancy complications. It was later discovered to be a teratogen and is no longer used.</span></li><li><span style=\"font-size:12pt;\">Exposure to DES in utero is known to cause the following conditions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>In girls</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">T-shaped uterus</span></li><li><span style=\"font-size:12pt;\">Cockscomb cervix</span></li><li><span style=\"font-size:12pt;\">Vaginal and cervical clear cell adenocarcinoma</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>In boys</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Micropenis</span></li><li><span style=\"font-size:12pt;\">Hypospadias</span></li><li><span style=\"font-size:12pt;\">Undescended testes</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma is the most common type of cervical cancer. It arises from the ectocervix, at the squamocolumnar junction. This type of cancer is not specifically associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adenocarcinoma</strong>: Adenocarcinoma arises from the endocervix and is not specifically linked to DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sarcoma botryoides</strong>: Sarcoma botryoides is a type of rhabdomyosarcoma that arises from the cervix. It presents as a pinkish polypoidal growth filling up the vagina completely and causes blood-tinged watery discharge. It is not associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">DES exposure in utero is specifically associated with an increased risk of clear cell adenocarcinoma of the vagina and cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg42</strong></span></p>",
      "correct_choice_id": 24290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}